
<html lang="en"     class="pb-page"  data-request-id="22223aff-d4b7-4ea1-81cc-046482254b54"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2013.56.issue-17;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm4006324;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Ligand–Protein Interactions of Selective Casein Kinase 1δ Inhibitors" /></meta><meta name="dc.Creator" content="Scot  Mente" /></meta><meta name="dc.Creator" content="Eric  Arnold" /></meta><meta name="dc.Creator" content="Todd  Butler" /></meta><meta name="dc.Creator" content="Subramanyam  Chakrapani" /></meta><meta name="dc.Creator" content="Ramalakshmi  Chandrasekaran" /></meta><meta name="dc.Creator" content="Kevin  Cherry" /></meta><meta name="dc.Creator" content="Ken  DiRico" /></meta><meta name="dc.Creator" content="Angela  Doran" /></meta><meta name="dc.Creator" content="Katherine  Fisher" /></meta><meta name="dc.Creator" content="Paul  Galatsis" /></meta><meta name="dc.Creator" content="Michael  Green" /></meta><meta name="dc.Creator" content="Matthew  Hayward" /></meta><meta name="dc.Creator" content="John  Humphrey" /></meta><meta name="dc.Creator" content="John  Knafels" /></meta><meta name="dc.Creator" content="Jianke  Li" /></meta><meta name="dc.Creator" content="Shenping  Liu" /></meta><meta name="dc.Creator" content="Michael  Marconi" /></meta><meta name="dc.Creator" content="Scott  McDonald" /></meta><meta name="dc.Creator" content="Jeff  Ohren" /></meta><meta name="dc.Creator" content="Vanessa  Paradis" /></meta><meta name="dc.Creator" content="Blossom  Sneed" /></meta><meta name="dc.Creator" content="Kevin  Walton" /></meta><meta name="dc.Creator" content="Travis  Wager" /></meta><meta name="dc.Description" content="Casein kinase 1δ (CK1δ) and 1ε (CK1ε) are believed to be necessary enzymes for the regulation of circadian rhythms in all mammals. On the basis of our previously published work demonstrating a CK1ε..." /></meta><meta name="Description" content="Casein kinase 1δ (CK1δ) and 1ε (CK1ε) are believed to be necessary enzymes for the regulation of circadian rhythms in all mammals. On the basis of our previously published work demonstrating a CK1ε..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 28, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm4006324" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm4006324" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm4006324" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm4006324" /></link>
        
    
    

<title>Ligand–Protein Interactions of Selective Casein Kinase 1δ Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm4006324" /></meta><meta property="og:title" content="Ligand–Protein Interactions of Selective Casein Kinase 1δ Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0011.jpeg" /></meta><meta property="og:description" content="Casein kinase 1δ (CK1δ) and 1ε (CK1ε) are believed to be necessary enzymes for the regulation of circadian rhythms in all mammals. On the basis of our previously published work demonstrating a CK1ε-preferring compound to be an ineffective circadian clock modulator, we have synthesized a series of pyrazole-substitued pyridine inhibitors, selective for the CK1δ isoform. Additionally, using structure-based drug design, we have been able to exploit differences in the hinge region between CK1δ and p38 to find selective inhibitors that have minimal p38 activity. The SAR, brain exposure, and the effect of these inhibitors on mouse circadian rhythms are described. The in vivo evaluation of these inhibitors demonstrates that selective inhibition of CK1δ at sufficient central exposure levels is capable of modulating circadian rhythms." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm4006324"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm4006324">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm4006324&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm4006324&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm4006324&amp;href=/doi/10.1021/jm4006324" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 6819-6828</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400619b" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400639z" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Ligand–Protein Interactions of Selective Casein Kinase 1δ Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scot++Mente">Scot Mente</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Arnold">Eric Arnold</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Todd++Butler">Todd Butler</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Subramanyam++Chakrapani">Subramanyam Chakrapani</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ramalakshmi++Chandrasekaran">Ramalakshmi Chandrasekaran</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Cherry">Kevin Cherry</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ken++DiRico">Ken DiRico</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angela++Doran">Angela Doran</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katherine++Fisher">Katherine Fisher</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Galatsis">Paul Galatsis</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Green">Michael Green</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew++Hayward">Matthew Hayward</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Humphrey">John Humphrey</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Knafels">John Knafels</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jianke++Li">Jianke Li</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shenping++Liu">Shenping Liu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Marconi">Michael Marconi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott++McDonald">Scott McDonald</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeff++Ohren">Jeff Ohren</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vanessa++Paradis">Vanessa Paradis</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Blossom++Sneed">Blossom Sneed</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Walton">Kevin Walton</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Travis++Wager">Travis Wager</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Pfizer Worldwide Research and Development, 700 Main Street, Cambridge, Massachusetts 02139, United States</span></div><div class="aff-info" id="aff2"><span class="aff-text">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div><div class="corresp-info"><strong>*</strong>Address: Pfizer Worldwide Research and Development, 700 Main Street, Cambridge, MA 02139. Tel: 617-395-0711. E-mail: <a href="/cdn-cgi/l/email-protection#99eafaf6edb7f4fcf7edfcd9e9fff0e3fcebb7faf6f4"><span class="__cf_email__" data-cfemail="5e2d3d312a70333b302a3b1e2e3837243b2c703d3133">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm4006324&amp;href=/doi/10.1021%2Fjm4006324" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 6819–6828</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 6, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 April 2013</li><li><span class="item_label"><b>Published</b> online</span>28 August 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 September 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm4006324" title="DOI URL">https://doi.org/10.1021/jm4006324</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6819%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DScot%2BMente%252C%2BEric%2BArnold%252C%2BTodd%2BButler%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D17%26contentID%3Djm4006324%26title%3DLigand%25E2%2580%2593Protein%2BInteractions%2Bof%2BSelective%2BCasein%2BKinase%2B1%25CE%25B4%2BInhibitors%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6828%26publicationDate%3DSeptember%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm4006324"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2290</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">16</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm4006324" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Ligand–Protein Interactions of Selective Casein Kinase 1δ Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Scot&quot;,&quot;last_name&quot;:&quot;Mente&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Arnold&quot;},{&quot;first_name&quot;:&quot;Todd&quot;,&quot;last_name&quot;:&quot;Butler&quot;},{&quot;first_name&quot;:&quot;Subramanyam&quot;,&quot;last_name&quot;:&quot;Chakrapani&quot;},{&quot;first_name&quot;:&quot;Ramalakshmi&quot;,&quot;last_name&quot;:&quot;Chandrasekaran&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Cherry&quot;},{&quot;first_name&quot;:&quot;Ken&quot;,&quot;last_name&quot;:&quot;DiRico&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;Doran&quot;},{&quot;first_name&quot;:&quot;Katherine&quot;,&quot;last_name&quot;:&quot;Fisher&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Galatsis&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Green&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;Hayward&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Humphrey&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Knafels&quot;},{&quot;first_name&quot;:&quot;Jianke&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Shenping&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Marconi&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;McDonald&quot;},{&quot;first_name&quot;:&quot;Jeff&quot;,&quot;last_name&quot;:&quot;Ohren&quot;},{&quot;first_name&quot;:&quot;Vanessa&quot;,&quot;last_name&quot;:&quot;Paradis&quot;},{&quot;first_name&quot;:&quot;Blossom&quot;,&quot;last_name&quot;:&quot;Sneed&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Walton&quot;},{&quot;first_name&quot;:&quot;Travis&quot;,&quot;last_name&quot;:&quot;Wager&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;6819-6828&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm4006324&quot;},&quot;abstract&quot;:&quot;Casein kinase 1δ (CK1δ) and 1ε (CK1ε) are believed to be necessary enzymes for the regulation of circadian rhythms in all mammals. On the basis of our previously published work demonstrating a CK1ε-preferring compound to be an ineffective circadian clock modulator, we have synthesized a series of pyrazole-substitued pyridine inhibitors, selective for the CK1δ isoform. Additionally, using structure-based drug design, we have been able to exploit differences in the hinge region between CK1δ and p38 to find selective inhibitors that have minimal p38 activity. The SAR, brain exposure, and the effect of these inhibitors on mouse circadian rhythms are described. The in vivo evaluation of these inhibitors demonstrates that selective inhibition of CK1δ at sufficient central exposure levels is capable of modulating circadian rhythms.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4006324&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4006324" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4006324&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4006324" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4006324&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4006324" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm4006324&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4006324&amp;href=/doi/10.1021/jm4006324" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm4006324" /></input><a href="/doi/pdf/10.1021/jm4006324" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm4006324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm4006324%26sid%3Dliteratum%253Aachs%26pmid%3D23919824%26genre%3Darticle%26aulast%3DMente%26date%3D2013%26atitle%3DLigand%25E2%2580%2593Protein%2BInteractions%2Bof%2BSelective%2BCasein%2BKinase%2B1%25CE%25B4%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D17%26spage%3D6819%26epage%3D6828%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291650" title="Alcohols">Alcohols</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jmcmar.2013.56.issue-17/production/jmcmar.2013.56.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/medium/jm-2013-006324_0011.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4006324&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Casein kinase 1δ (CK1δ) and 1ε (CK1ε) are believed to be necessary enzymes for the regulation of circadian rhythms in all mammals. On the basis of our previously published work demonstrating a CK1ε-preferring compound to be an ineffective circadian clock modulator, we have synthesized a series of pyrazole-substitued pyridine inhibitors, selective for the CK1δ isoform. Additionally, using structure-based drug design, we have been able to exploit differences in the hinge region between CK1δ and p38 to find selective inhibitors that have minimal p38 activity. The SAR, brain exposure, and the effect of these inhibitors on mouse circadian rhythms are described. The in vivo evaluation of these inhibitors demonstrates that selective inhibition of CK1δ at sufficient central exposure levels is capable of modulating circadian rhythms.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18608" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18608" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Casein kinase 1 protein kinases (CK1s) function as regulators of signal transduction pathways and are involved in Wnt signaling and circadian rhythms.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> We have previously demonstrated that dual CK1δ/ε inhibitors, such as PF-670462 (compound <b>1</b>, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>), have robust phase delay in animal models of circadian rhythm,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> while selective CK1ε compounds have been shown to be ineffective clock modulators.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> As such, CK1δ potency appears to be a key factor in the design of a circadian rhythm modulating agent.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/medium/jm-2013-006324_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4006324&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A number of aspects can potentially confound the design of a successful CNS-active CK1δ inhibitor. These include poor whole-cell potency, a lack of selectivity, and incorrectly aligned ADMET properties. Targeting a kinase for CNS indications may be particularly challenging, due to the balancing of free drug levels necessary to achieve central exposure with potential peripheral safety considerations. In fact, due to the polar nature of many kinase scaffolds, peripheral-free drug exposure may be as much as 2–3-fold higher than the relevant free central exposure. Since many approved kinase drugs are known to have cardiotoxicity,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> imbalance between peripheral and central drug levels is a clear area of concern. Leveraging the CNS drug analysis and CNS MPO algorithm, molecules were designed in high desirability space (CNS MPO > 4) to increase the odds of identifying compounds with good CNS exposure and aligned ADME attributes.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Although many have highlighted the potential benefits of drug promiscuity,<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> we share in the opinion that overly promiscuous compounds are “forbiddingly dangerous...without a rational strategy to control specificity...”<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and would be a higher risk during clinical assessment.</div><div class="NLM_p">While the previously described compound <b>1</b> has proven to be a useful tool for demonstrating the role of CK1δ inhibitors for modulation of circadian rhythms in vivo, it suffers from poor off-target pharmacology. Recent structural examinations of <b>1</b> bound to CK1δ and CK1ε suggest a very similar binding to both isoforms<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> and help to explain why <b>1</b> is only slightly CK1δ preferring. In addition to both CK1δ and CK1ε, <b>1</b> was active (>50% inhibition at 1 μM) against six kinases: PKAα, p38, MAP4K4, CK1α, LCK, and EGFR. This nonoptimal selectivity profile necessitated the need for modification to build in greater selectivity and a more favorable CNS profile, with the ultimate goal of advancing a selective CK1δ inhibitor to the clinic to test the circadian rhythm shift mechanism of action (MOA). We began our pursuit to identify a selective CK1δ inhibitor by screening our internal compound collection for viable hits. Compounds <b>1</b> and <b>2</b> were identified from this HTS.</div><div class="NLM_p last">This paper describes the use of structure-based drug design to develop ATP-competitive CK1δ preferring inhibitors. We report the X-ray structures of four pyrazole-substituted pyridine compounds bound to CK1δ and compare their binding characteristics to those of a similar inhibitor bound to p38, as this enzyme proved to be the most challenging of the off-target kinase activities. We find that the binding mode of the more selective inhibitors is characterized by an interaction with a glycine residue (Gly110) of the kinase. Although this residue is conserved in p38 and CK1δ, the adjacent hinge residue, Pro87, results in a framework that is both rigid and unique. These inhibitors represent the first such CK1δ-preferring ligands designed with a clear effort toward gaining both enzyme activity and central exposure.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> illustrates the synthesis of CK1δ-preferring inhibitors <b>2</b>–<b>4</b>. Commercially available pyridine <b>8</b> and ethyl 4-fluorobenzoate <b>9</b> were condensed in the presence of LHMDS to give ketone <b>10</b>, which was directly treated with dimethylformamide dimethyl acetal (DMF-DMA) to afford enamine <b>11</b> as a mixture of <i>E</i>,<i>Z</i> isomers in ∼1:8 ratio. Reacting <b>11</b> with methyl hydrazine at 0 °C resulted in a mixture of <i>N</i>-methylpyrazole regioisomers that, after trituration with 1:1 ether/heptane, gave compound <b>2</b> in 31% isolated yield over three steps.</div><div class="NLM_p">Oxidation of <b>2</b> with <i>m</i>CPBA afforded <i>N</i>-oxide <b>13</b> in 95% yield, which upon cyanation with trimethylsilylcyanide (TMSCN) resulted in an 86% yield of pyridylnitrile <b>14</b>. Catalytic hydrogenation using sponge nickel and 7 N ammonia in MeOH gave amine <b>15</b> in 99% yield, which upon heating with ethyl formate produced formamide <b>16</b>. <i>N</i>-Methylation, using MeI, resulted in <b>17</b> in 90% yield. Subsequent hydrolysis using methanolic hydrochloric acid provided the target compound <b>4</b> in reasonable yield (56%).</div><div class="NLM_p">The desired target compound <b>3</b> could be prepared in two steps via standard reaction conditions. Namely, pyridyl nitrile <b>14</b> could be hydrolyzed to methyl ester <b>18</b> using acidic methanol in 55% yield. Alcohol <b>3</b> could then be obtained by LAH reduction of <b>18</b> in 20% yield.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/medium/jm-2013-006324_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 2-Substituted Pyridyl Analogs <b>2</b>–<b>4</b></div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4006324&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 2 equiv of LHMDS, THF, 0 °C to rt, 3.75 h (crude); (ii) 1.1 equiv of DMF-DMA, reflux, 72 h (crude); (iii) 1.2 equiv of methylhydrazine, EtOH, 0 °C, 3 h (31% over three steps); (iv) 1.2 equiv of <i>m</i>CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 18 h (99%); (v) 1.3 equiv of TMS-CN, 1.2 equiv of dimethylcarbamoyl chloride, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h (86%); (vi) H<sub>2</sub> (50 psi), catalytic sponge Ni, 7 N ammonia in MeOH, THF, rt, 2 h (99%); (vii) ethyl formate, 70 °C, 3 h (80%); (viii) 1.5 equiv of MeI, 1.2 equiv of NaH, THF, rt, 18 h (90%); (ix) MeOH/12 N HCl (10:1 v/v), reflux, 90 min, followed by isopropyl alcohol/MeOH recryst 56%); (x) 1.25 M HCl/MeOH, reflux 20 h, (55%); (xi) 1 M LAH/THF, rt, 30 min (25%).</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/medium/jm-2013-006324_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Fused Oxazepine <b>5</b></div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4006324&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 2 equiv of <i>n</i>-BuLi, THF, −70 °C then 1.5 equiv of <b>20</b>, 1.5 h (44%); (ii) 0.9 equiv of <b>21</b>, 2 mol % of Pd(OAc)<sub>2</sub>, 4 mol % of Xphos, 1.2 equiv of Cs<sub>2</sub>CO<sub>3</sub>, ACN/H<sub>2</sub>O (5:1), reflux, 3 h (80%); (iii) 1.4 equiv of <b>24</b>, 1.7 equiv of NaH, THF, −20 to −5 °C, 4 h, (70%); (iv) concd H<sub>2</sub>SO<sub>4</sub>, 110 °C, 10 min; (v) 5 N NaOH, pH 7.0 phosphate buffer, 110 °C, 3 h, 80% from <b>25</b>; (vi) 2.25 equiv of LAH/THF, 50 °C, 2 h; (vii) 2 equiv of <i>p</i>-toluenesulfonic acid, MeOH, 42% from <b>26</b>.</p></p></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> illustrates the synthesis of CK1δ/ε inhibitor <b>5</b>. Pinacol borane <b>21</b> was prepared by lithiation of bromopyrazole <b>19</b> followed by borolation with <b>20</b> in 44% yield. Subsequent Suzuki coupling of iodide <b>22</b> with <b>21</b> using cesium carbonate, Xphos, and Pd(OAc)<sub>2</sub> yielded diarylpyrazole <b>23</b> in 80% yield. S<sub>N</sub>Ar displacement using deprotonated <i>N</i>-Boc ethanolamine <b>24</b> generated pyridyl ether <b>25</b> in 81% yield. Removal of the Boc protecting group afforded amine <b>26</b> and subsequent one-pot cyano-hydrolysis and ring closure yielded oxazepinone <b>27</b> in 80% over two steps. The desired oxazepine <b>5</b> was then prepared by reduction of <b>27</b> using lithium aluminum hydride followed by conversion to the tosylate salt in 42% yield</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/medium/jm-2013-006324_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Morpholine <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4006324&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 5 mol % of Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, 2 equiv of CsF, DMF, 140 °C, 2 h (80%); (ii) 1 equiv of <i>n</i>-BuLi, toluene, 1 equiv of <b>30</b>, −78 °C, 1.5 h (22%) (iii) 10 equiv of 1.0 M HCl/EtOH, EtOH, rt, 12 h (assumed 100%); (iv) 4 equiv of NaBH<sub>4</sub>, MeOH, −40 °C to rt, 30 min (26%).</p></p></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> illustrates the synthesis of CK1δ/ε inhibitor <b>6</b>. The synthesis started with Suzuki coupling of a commercially available pyridyl iodide <b>28</b> and boronate intermediate <b>21</b> that resulted in 80% yield of intermediate <b>29</b> as a white solid. Temperature-controlled halogen–metal exchange of <b>29</b> followed by addition of morpholinone <b>30</b> at −78 °C yielded keto ether intermediate <b>31</b> as an off-white foam, which was subjected to acidic hydrolysis conditions and subsequent ring closure to yield imine <b>32</b>. Reduction of the imine with sodium borohydride resulted in the isolation of racemic morpholine as a white foam in 26% yield. Preparative chiral HPLC was then used to separate the (−)-antipode of <b>6</b> from its (+)-antipode.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure, Pharmacology, and Exposure Data</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/medium/jm-2013-006324_0008.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values reported as geometric means of <i>n</i> > 2 independent experiments, unless otherwise noted.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Exposures are maximum concentrations at a 56 mg/kg dose, unless otherwise noted.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">32 mg/kg dose.</p></div></div><div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52881" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52881" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Structure-Based Drug Design</h3><div class="NLM_p">Compound <b>2</b> was a high-throughput screening hit that was previously cocrystallized with the p38 enzyme.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> The X-ray structure of <b>2</b> bound to p38 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) shows the pyridine core interacting as a single point binder with the hinge (Met109), the pyrazole nitrogen interacting through a water molecule with the catalytic Lys38, and the <i>p</i>-fluoro aryl ring occupying the hydrophobic selectivity pocket of p38. In our hands, <b>2</b> was found to also be a potent CK1δ inhibitor (IC<sub>50</sub> = 48 nM), with moderate whole-cell activity (EC<sub>50</sub> = 545 nM). Evaluation of <b>2</b> at a 1 μM concentration against a larger selectivity panel, consisting of 103 kinases, found that <b>2</b> inhibited nine kinases at greater than 50%: ABL (61%), LYN (70.5%), MAPK14 (55%), p38 (85%), JNK2/3 (48%), ROCK2 (52%), EGFR (80%), MAP4K4 (66%), SAPK2A (96%).</div><figure id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/medium/jm-2013-006324_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Binding of inhibitors to p38a (red box; compound <b>2</b>) and CK1δ (ribbon diagram and green boxes; compounds <b>3</b>–<b>6</b>). All structures share a common interaction of the pyridine core interacting as a single point binder with the hinge (Met109/Leu85) of p38/CK1δ. Also conserved in all structures is the pyrazole nitrogen interacting through a water molecule with the catalytic Lys38, as well as the <i>p</i>-fluoro aryl ring occupying the hydrophobic selectivity pocket of p38. Selective CK1δ inhibitors (<b>3</b>–<b>6</b>) make additional hinge interaction with the proline carbonyl of CK1δ. Compounds <b>3</b>–<b>6</b> also hydrogen bond to the carbonyl oxygens of both residues Leu85 and Gly86.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4006324&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The relative selectivity of compound <b>2</b> over this subset of the kinase pharmacology can be attributed largely to the <i>p</i>-fluoro aryl group, which interacts with the so-called “hydrophobic” selectivity pocket. This feature exists in both the CK1δ and p38 enzymes despite differences in primary sequence; in p38, this is comprised of Thr-Val-Leu residues, while in CK1δ/ε it is comprised of Met-Val-Met residues.</div><div class="NLM_p">An obvious and important difference between these kinases was the proline residue (Pro87) of the backbone of CK1δ that is not present in p38. This difference was targeted in the design of novel and selective CK1δ inhibitors, as exemplified by compound <b>3</b> (Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The primary hydroxyl group of compound <b>3</b> makes a selective interaction with the proline (Pro87) carbonyl of CK1δ that was in an altered conformation compared to p38 (Ala111). Although the same carbonyl exists in both enzymes, the flexible hinge of p38 positioned this functionality in a different orientation relative to CK1δ, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. Previous studies have shown that p38 ligands containing the pyridine hinge binding motif can induce a peptide flip in the hinge region by introduction of an amino group ortho to the pyridine nitrogen.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> With these ligands, the amino group H-bonds to the backbone carbonyl of the hinge residue (Met109 in p38), yielding improved potency and p38 selectivity. In contrast, the proline of CK1δ holds that same carbonyl at a different angle and renders the ligand-induced “peptide flipping” all but impossible. Compound <b>3</b> adds an additional methyl spacer between the pyridine acceptor and the putative donor in an attempt to gain selectivity. Indeed, <b>3</b> proved to increase the p38 selectivity roughly 50 times, whereas <b>2</b> was only 3 times more selective. However, the hydroxyl group was a concern due to its potential for rapid metabolism.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/medium/jm-2013-006324_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. View of backbone carbonyls of CK1δ (white wire with compound <b>3</b>) and p38 (green wire). Comparing the angle between the carbonyl groups (C═O vector) gives values of 41 for Leu85 (Met109 in p38), 117 for the Gly86 (Gly110 in p38), and 80 for Pro87 (Ala111 in p38).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4006324&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>4</b> was similarly designed to retain the new-found selectivity handle and maintain or improve potency at reasonable levels of central exposure.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> This was accomplished through inclusion of a methylamine group, which also displaced nearby water molecules and shielded the H-bond to the carbonyl.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The potency of <b>4</b> improved roughly 2 times over that of compound <b>3</b> and the selectivity over p38 widened to 230 times. Importantly, compound <b>4</b> was completely selective in our kinase panel (0/43, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) and showed large improvements in cellular activity. Additionally, <b>4</b>, when dosed subcutaneously (sc), possessed good central exposure (7.5 μM free brain exposure; <i>C</i><sub>b,u</sub>/<i>C</i><sub>p,u</sub> = 0.78). However, the addition of a basic center was found to increase hERG liability.</div><div class="NLM_p">The next round of designs produced compounds <b>5</b> and <b>6</b>, which have in common the inclusion of a group designed to lower the basicity of the amine, a strategy which has been used to reduce the affinity of basic compounds for the hERG channel.<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21-23)</a> With the inclusion of the oxazepine ring, compound <b>5</b> had improved its CK1δ potency to 6.5 nM and also proved to be the most potent compound in the whole cell assay at 39 nM. The hERG activity of compound <b>5</b> was reduced ∼6 times relative to compound <b>4</b>. Published hERG models have suggested the importance of ligand properties, such as basicity, hydrophobicity, and ligand flexibility, on channel block.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> Conceptually, compounds possessing a basic center are thought to interact with aromatic residues (Phe656), leaving polar heterocycles, such as the pyrazole group of our ligands, to interact with the channel via specific H-bonding interactions to a serine residue (Ser624) at the top of the pore.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> The oxazepene <b>5</b> may benefit from both the reduction of the p<i>K</i><sub>a</sub> (5.93 versus 7–8) as well as conformational restriction, which may hinder the spacing between pharmacophoric elements.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Although <b>5</b> maintained 100 times selectivity over p38, at 654 nM, it was markedly more potent versus p38 than <b>4</b>. In addition, two additional kinase activities were detected in the kinase panel (CK1α and MAP4K4). While the free plasma concentration (<i>C</i><sub>p,u</sub> following sc dosing) of <b>5</b> was comparable to that of <b>4</b>, free brain levels were now disproportionally lower by roughly 2.5 times (<i>C</i><sub>b,u</sub>/<i>C</i><sub>p,u</sub> = 0.33), narrowing the gains made from the reduction of the hERG activity.</div><div class="NLM_p">Morpholines are also well-known to reduce basicity via a negative inductive effect. This concept was introduced into the scaffold of compound <b>2</b> to produce compound <b>6</b>. Docking<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> of <b>6</b> into the CK1δ X-ray structure also suggested the ability to increase the potency of the ligand on the receptor for this series through the creation of additional interactions with Ile15. This compound was the most potent compound measured in the enzyme assay (5.3 nM) and very potent in the whole cell assay (89.9 nM). Compound <b>6</b> also maintained good p38 and overall kinase selectivity versus our panel.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/medium/jm-2013-006324_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Mouse circadian rhythm shift (<i>y</i>-axis, in hours) versus compound (<i>x</i>-axis). Top and lower bounds of boxes refer to 75th and 25th percentile values. Mean shifts are −1.5, −2.9, and −1.2 h (<i>p</i> < 0.001 for all three) for compounds <b>4</b>, <b>5</b>, and <b>6</b> respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4006324&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Selected compounds from Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> were screened in an in vivo mouse circadian rhythm model.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> illustrates the magnitude of circadian rhythm shift observed in mice following 3 days of drug treatment (56 mg/kg subcutaneous dose). For the mice treated in these studies, the shifts refer to the difference between the start of the active period after dosing versus before dosing. All compounds demonstrate significant (<i>p</i> < 0.001) phase shift delay, with <b>5</b> showing the largest mean shift of 2 h and 55 min.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14204" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14204" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have illustrated that compounds <b>3</b>–<b>6</b> are potent CK1δ inhibitors that gain a large degree of selectivity over p38 via a unique H-bonding interaction with the hinge region, in particular, placement of a CH<sub>2</sub>-spaced heteroatom capable of donating a H-bond to the carbonyl of the hinge Pro in CK1δ. Larger cyclic amines, oxazepine and morpholine, were designed to maintain this motif and have been shown to shift mouse circadian rhythms in vivo. These analogues demonstrate the utility of structure-based drug design to address issues of potency and selectivity. However, these analogues also suffer mild hERG pharmacology. For instance, <b>5</b>, though active in vivo, is present at 8.8 μM maximum free plasma concentration at this dose, which translates to an approximate 3-fold hERG TI (hERG EC<sub>50</sub>/<i>C</i><sub>p,u</sub>). Future publications will highlight compounds designed to address this issue while in vivo efficacy is maintained.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11240" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11240" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Information</h3><div class="NLM_p last">All solvents and reagents were obtained from commercial sources and were used as received. Compound <b>1</b> is commercially available (Tocris), <b>2</b> was prepared using published methodology,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and <b>3</b>–<b>6</b> were prepared as discussed below. All reactions were followed by TLC (TLC plates F254, Merck) or LCMS (liquid chromatography–mass spectrometry) analysis. Varian 300, 400, or 500 MHz instruments were used to obtain <sup>1</sup>H and <sup>13</sup>C NMR spectra in deuterated solvents. All proton shifts are reported in δ units (ppm) and were measured relative to signals for chloroform (7.26 ppm) or methanol (3.30 ppm). All <sup>13</sup>C shifts are reported in δ units (ppm) relative to the signals for chloroform (77 ppm) or methanol (49 ppm) with <sup>1</sup>H decoupling. All coupling constants (<i>J</i> values) are reported in hertz (Hz). GCMS were recorded on an HP 6890 GC system equipped with a 5973 mass selective detector (stationary phase, HP-1, fused silica, 12 m × 0.202 mm × 0.33 μm; temperature limits, −60 to 325 °C; ramp rate = 30 °C/min; solvent delay = 0.4 min). Analytical analyses by UPLC were performed on a Waters Acquity system with PDA detection (UV 210 nm) at 45 °C and flow rate 0.5 mL/min, with a gradient of 95/5 buffer/acetonitrile (0–7.55 min), 10/90 buffer/acetonitrile (7.55–7.85 min), 95/5 buffer/acetonitrile (8.10–10.30 min) using the following columns and buffers: Waters BEH C8 column (2.1 × 100 mm, 1.7 um) with 50 mM sodium perchlorate/0.1% phosphoric acid or 10 mM ammonium bicarbonate as buffer; Waters BEH RP C18 column (2.1 × 100 mm, 1.7 um) or Waters HSS T3 (2.1 × 100 mm, 1.8 um) column with 0.1% methanesulfonic acid buffer. Mass spectra were recorded on a Micromass ADM atmospheric pressure chemical ionization instrument (MS, APCI). High-resolution mass spectra were obtained on an Agilent 6620 LC-MS TOF equipped with a Zorbax Eclipse column (50 mm × 4.6 mm, 1.8 μm XDB-C18) using 0.1% formic acid aqueous as mobile phase A1 and acetonitrile containing 0.1% formic acid as mobile phase B1. Column chromatography was carried out on silica gel 60 (32–60 mesh, 60 Å) or on prepacked Biotage columns. The purities of final compounds <b>3</b>–<b>6</b> as measured by UPLC were found to be above 95%.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 1-(4-Fluorophenyl)-2-(pyridine-4-yl)ethanone (<b>10</b>)</h3><div class="NLM_p last">To a solution of 4-methylpyridine (48 g, 500 mmol) in THF (100 mL) under N<sub>2</sub> at 0 °C was slowly added LHMDS (1.0 M in THF, 1030 mL, 1030 mmol). Once addition was complete, a dark brown solution resulted and this was stirred at 0 °C for 1 h. Ethyl 4-fluorobenzoate (85 g, 74 mL, 500 mmol) in THF (100 mL) was added slowly via an addition funnel and stirring was continued at 0 °C for another 45 min before the reaction was slowly warmed to rt. After stirring for 2 h at rt, the reaction was quenched with 50 mL of water. This reaction mixture was cooled to 0 °C, adjusted to pH 7.0 by the addition of ∼50 mL of 6 N HCl, and extracted with EtOAc (2 × 400 mL). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude solid was triturated with 50 mL of heptanes to afford the title compound (108 g) as a light yellow solid. This material was used without purification in the subsequent step. A portion of this solid was subjected to silica gel chromatography using 100% EtOAc to afford ∼95% pure title compound as a light yellow colored solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.45 (dd, <i>J</i> = 1.6, 4.3, 2H), 7.90–7.95 (m, 2H), 7.09 (dd, <i>J</i> = 1.6, 4.3, 2H), 7.01–7.07 (m, 2H), 4.13 (s, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 194.3, 166.6 (d, <i>J</i><sub>F–C</sub> = 255.5), 149.9, 143.3, 132.6 (d, <i>J</i><sub>F–C</sub> = 3.7), 130.6 (d, <i>J</i><sub>F–C</sub> = 9.6), 124.9, 113.6 (d, <i>J</i><sub>F–C</sub> = 22.1), 44.4. HRMS: calcd for C<sub>13</sub>H<sub>10</sub>FNO 216.0819 (M + H)<sup>+</sup>, found 216.0816.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> (<i>Z</i>)-(Dimethylamino)-1-(4-fluorophenyl)-2-(pyridin-4-yl)prop-2-en-1-one (<b>11</b>)</h3><div class="NLM_p last">To a solution of ketone <b>10</b> (106 g, 500 mmol) in THF (500 mL) was added dimethylformamide dimethyl acetal (76 mL, 572 mmol), and the mixture was refluxed at 75 °C for 72 h. The reaction was cooled to rt and concentrated down under reduced pressure to afford the title compound as a reddish gum that was taken crude to the next step. A portion of this material was purified by silica gel chromatography using 5% MeOH/EtOAc to afford 95% pure title compound as light yellow solid. <sup>1</sup>H NMR showed a ∼1:8 mixture of <i>E</i>,<i>Z</i>-isomers. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz), major Z-isomer: δ 8.44 (dd, <i>J</i> = 1.6, 4.5, 2H), 7.36–7.41 (m, 2H), 7.31 (s, 1H), 7.01 (dd, <i>J</i> = 1.6, 4.5, 2H), 6.88–6.95 (m, 2H), 2.72 (s, 6H). <sup>13</sup>C (CDCl<sub>3</sub>, 100 MHz): δ 192.4, 161.2 (d, <i>J</i><sub>F–C</sub> = 250.3), 154.5, 148.8, 145.7, 137.0 (d, <i>J</i><sub>F–C</sub> = 3.7), 130.7 (d, <i>J</i><sub>F–C</sub> = 8.8), 126.7, 114.7 (d, <i>J</i><sub>F–C</sub> = 22.1), 108.5, 44.4. HRMS: calcd for C<sub>16</sub>H<sub>15</sub>FN<sub>2</sub>O 271.1241 (M + H)<sup>+</sup>, found 271.1240.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 4-(3-(4-Fluorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)pyridine (<b>2</b>)</h3><div class="NLM_p last">To a solution of enamine <b>11</b> (140 g, 520 mmol) in EtOH (200 mL) at 0 °C was added dropwise a solution of methylhydrazine (33 mL, 624 mmol) in EtOH (70 mL). After 3 h of stirring at 0 °C, the reaction was concentrated under reduced pressure, redissolved in 500 mL of EtOAc, and washed with 75 mL of water and 50 mL of satd brine. The organics were dried over Na<sub>2</sub>SO<sub>4</sub> and filtered, and the concentrate was passed through a silica plug and rinsed with 2 L each of EtOAc and 10% MeOH/EtOAc. The filtrate was concentrated under reduced pressure and triturated with 1:1 heptanes/Et<sub>2</sub>O (200 mL). The title compound (42 g, 31%) was recovered as a white solid after filtration and drying. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.49–8.52 (m, 2H), 7.60 (s, 1H), 7.42–7.47 (m, 2H), 7.14–7.17 (m, 2H), 7.02–7.09 (m, 2H), 4.00 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 162.9 (d, <i>J</i><sub>F–C</sub> = 247.2), 150.3, 148.9, 141.2, 131.9 (d, <i>J</i><sub>F–C</sub> = 8.0), 130.9, 129.0 (d, <i>J</i><sub>F–C</sub> = 3.2), 122.9, 118.4, 114.7 (d, <i>J</i><sub>F–C</sub> = 21.8), 39.5. HRMS: calcd for C<sub>15</sub>H<sub>12</sub>FN<sub>3</sub> 254.1088 (M + H)<sup>+</sup>, found 254.1080.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 4-(3-(4-Fluorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)pyridine 1-Oxide (<b>13</b>)</h3><div class="NLM_p last">To a 0 °C solution of of diarylpyrazole <b>2</b> (42.0 g, 163.9 mmol) in 300 mL of DCM was added <i>m</i>CPBA (42 g, 197 mmol). The reaction was warmed to rt,  stirred for 18 h, and then purified directly by silica gel chromatography using 5–50% MeOH/EtOAc to afford 44 g (99%) of the title compound as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.04–8.08 (m, 2H), 7.57 (s, 1H), 7.36–7.42 (m, 2H), 7.07–7.11 (m, 2H), 7.00–7.06 (m, 2H), 3.95 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 162.7 (d, <i>J</i><sub>F–C</sub> = 248.7), 148.3, 139.0, 131.5, 130.2, 130.1(d, <i>J</i><sub>F–C</sub> = 8.1), 128.5 (d, <i>J</i><sub>F–C</sub> = 3.7), 124.6, 116.5, 115.7 (d, <i>J</i><sub>F–C</sub> = 22.1), 39.2. HRMS: calcd for C<sub>15</sub>H<sub>12</sub>FN<sub>3</sub>O 270.1037 (M + H)<sup>+</sup>, found 270.1032.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 4-(3-(4-Fluorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)picolinonitrile (<b>14</b>)</h3><div class="NLM_p last">To a 0 °C suspension of <i>N</i>-oxide <b>13</b> (57 g, 212 mmol) and trimethylsilyl cyanide (28 g, 275 mmol) in 250 mL of DCM was added dropwise dimethyl carbamoyl chloride (24 mL, 254 mmol). Once addition was complete, the resulting clear solution was stirred at rt for 16 h. The reaction was treated with 150 mL of satd K<sub>2</sub>CO<sub>3</sub> and diluted with 250 mL of DCM. After one more extraction of the aqueous phase with 200 mL of DCM, the combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The concentrate was slurried with 200 mL of Et<sub>2</sub>O and filtered to recover 51 g (86%) of the title compound as a light yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.54 (dd, <i>J</i> = 5.3, 0.6, 1H), 7.68 (s, 1H), 7.56 (dd, <i>J</i> = 1.68, 0.8, 1H), 7.38–7.43 (m, 2H), 7.32 (dd, <i>J</i> = 5.1, 1.8, 1H), 7.05–7.12 (m, 2H), 4.01 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 162.6 (d, <i>J</i><sub>F–C</sub> = 248.1), 151.2, 148.9, 142.5, 134.2, 130.9, 130.1 (d, <i>J</i><sub>F–C</sub> = 8.1), 128.3 (d, <i>J</i><sub>F–C</sub> = 3.7), 126.8, 125.0, 117.2, 116.1, 115.8 (d, <i>J</i><sub>F–C</sub> = 21.4), 39.4. HRMS: calcd for C<sub>16</sub>H<sub>11</sub>FN<sub>4</sub> 279.1041 (M + H)<sup>+</sup>, found 279.1036.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (4-(3-(4-Fluorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-2-yl)methanamine (<b>15</b>)</h3><div class="NLM_p last">To a nitrogen-sparged 2 L pressure autoclave was added sponge nickel (Johnson Matthey type A-4000, 23 g, 387 mmol), nitrile <b>14</b> (35 g, 125.8 mmol), and 7 N ammonia in methanol (1225 mL, 8.58 mol). The vessel was purged with nitrogen (pressurized to 50 psi and then vented) three times and then purged with hydrogen (pressurized to 50 psi and vented) three times. The mixture was pressurized to 50 psi with hydrogen and shaken for 2 h. After purging with nitrogen three times, the reaction was filtered (Celite) and washed methanol (350 mL). The filtrate was concentrated under reduced pressure to recover 36 g (99%) of the title compound as a pink gum. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 400 MHz): δ 8.47 (d, <i>J</i> = 5.1, 1H), 8.02 (s, 1H), 7.40–7.46 (m, 2H), 7.31 (br s, 1H), 7.21 (dd, <i>J</i> = 5.3, 1.8, 1H), 7.10–7.16 (m, 2H), 4.17 (s, 2H), 3.98 (s, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>, 100 MHz): δ 165.7 (d, <i>J</i><sub>F–C</sub> = 245.9), 154.1, 150.7, 150.0, 144.0, 133.5, 131.9 (d, <i>J</i><sub>F–C</sub> = 8.1), 130.6 (d, <i>J</i><sub>F–C</sub> = 3.0), 123.5, 122.1, 118.7, 116.7 (d, <i>J</i><sub>F–C</sub> = 22.1), 44.2, 39.4. HRMS: calcd for C<sub>16</sub>H<sub>15</sub>FN<sub>4</sub> 283.1354 (M + H)<sup>+</sup>, found 283.1349.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> <i>N</i>-((4-(3-(4-Fluorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-2-yl)methyl)formamide (<b>16</b>)</h3><div class="NLM_p last">Amine <b>15</b> (35 g, 124 mmol) in ethyl formate (500 mL) was heated to 70 °C. After 3 h of heating, the reaction was cooled to rt, concentrated under reduced pressure, passed through a 3.5 in. × 5 in. silica gel plug flushing first with 100% EtOAc to remove the less polar impurities and then eluting with 25% MeOH in EtOAc to yield 31 g (80%) of the title compound as light yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) showed a ∼9:1 mixture of rotamers; major isomer: δ 8.36 (d, <i>J</i> = 5.3, 1H), 8.27 (s, 1H), 7.61 (s, 1H), 7.37–7.43 (m, 2H), 7.14 (s, 1H), 7.00–7.06 (m, 4H), 4.52 (d, <i>J</i> = 5.3, 2H), 3.97 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 167.0 (d, <i>J</i><sub>F–C</sub> = 247.4), 161.1, 156.1, 149.0, 148.6, 141.9, 130.7, 129.2 (d, <i>J</i><sub>F–C</sub> = 8.1), 126.6 (d, <i>J</i><sub>F–C</sub> = 3.0), 121.4, 120.5, 117.6, 113.9 (d, <i>J</i><sub>F–C</sub> = 21.4), 42.9, 39.1. HRMS: calcd for C<sub>17</sub>H<sub>15</sub>FN<sub>4</sub>O 311.1303 (M + H)<sup>+</sup>, found 311.1301.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>N</i>-((4-(3-(4-Fluorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)pyridine-2-yl)methyl)-<i>N</i>-methylformamide (<b>17</b>)</h3><div class="NLM_p last">Sodium hydride (4.8 g,120 mmol) was added to formamide <b>16</b> (31 g, 99 mmol) in THF (992 mL). After 30 min of stirring, methyl iodide (21 g, 149 mmol) was added. The resulting suspension was stirred at rt for 18 h, quenched with 150 mL of saturated NaHCO<sub>3</sub>, and extracted with DCM (3 × 400 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and then filtered through a 1 in. × 3 in. silica plug layered with 1 in. of MgSO<sub>4</sub>. The filtrate was concentrated under reduced pressure to give 29 g (90%) of the title compound as light yellow colored solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) ∼1:1 mixture of rotamers: δ 8.40/8.35 (two d’s, 2H total, <i>J</i> = 5.3), 8.16 (s, 1H), 8.04 (s, 1H), 7.59 (d, 2H, <i>J</i> = 2.3), 7.34–7.39 (m, 4H total), 6.96–7.06 (m, 8H total), 4.54 (s, 2H), 4.39 (s, 2H), 3.93 (s, 3H), 3.92 (s, 3H), 2.87 (s, 3H), 2.73 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) ∼1:1 mixture of rotamers: δ 163.8,163.7, 162.9, 162.5, 161.3, 156.1, 156.2, 149.8, 149.3, 148.5, 148.4, 142.0, 130.7, 130.6, 130.2, 130.1, 130.0, 128.9, 128.7, 121.5, 121.1, 120.3, 119.9, 117.6, 117.5, 115.5, 115.4, 115.3, 115.2, 54.9, 49.5, 39.7, 34.7, 29.8. HRMS: calcd for C<sub>18</sub>H<sub>17</sub>FN<sub>4</sub>O 325.1459 (M + H)<sup>+</sup>, found 325.1455.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 1-(4-(3-(4-Fluorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)pyridine-2-yl)-<i>N</i>-methylmethanamine (<b>4</b>)</h3><div class="NLM_p last"><i>N</i>-Methylformamide <b>17 </b>(29g, 89 mmol) in 580 mL of 1:10 v/v of 12 N HCl:MeOH was refluxed for 30 min. The reaction was cooled to rt, concentrated under reduced pressure, and triturated with MeOH (6 × 50 mL) to afford 26 g of light cream colored solid. Crystallization from boiling isopropyl alcohol/MeOH (4:1 ratio) afforded 18.5 g (56%) of the title compound as a white, cottony solid. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 400 MHz): δ 8.63 (d, <i>J</i> = 6.3, 1H), 8.53 (s, 1H), 8.26 (d, <i>J</i> = 1.8, 1H), 7.69 (dd, <i>J</i> = 6.3, 2.0, 1H), 7.51–7.56 (m, 2H), 7.19–7.26 (m, 2H), 4.60 (s, 2H), 4.05 (s, 3H), 2.88 (s, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>, 100 MHz): δ 162.2 (d, <i>J</i><sub>F–C</sub> = 247.6), 153.2, 152.1, 147.3, 144.5, 136.4, 130.1 (d, <i>J</i><sub>F–C</sub> = 8.7), 129.3 (d, <i>J</i><sub>F–C</sub> = 3.6), 126.7, 125.1, 115.0 (d, <i>J</i><sub>F–C</sub> = 22.3), 117.2, 50.3, 40.3, 34.6. HRMS: calcd for C<sub>17</sub>H<sub>17</sub>FN<sub>4</sub> 297.151 (M + H)<sup>+</sup>, found 297.1504.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Methyl 4-(3-(4-Fluorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)picolinate (<b>18</b>)</h3><div class="NLM_p last">Nitrile <b>14</b> (330 mg, 1.18 mmol) and HCl/MeOH (1.25 M, 16 mL, 20.4 mmol) were refluxed for 20 h and then cooled to rt and concentrated under reduced pressure. The residue was dissolved in 100 mL of DCM and basified using 20 mL of satd NaHCO<sub>3</sub>. The organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to recover 370 mg of crude product as semisolid. This was subjected to silica gel chromatography using 75–100% EtOAc/heptanes to afford 208 mg (55%) of the title compound as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.51 (d, <i>J</i> = 5.1, 1H), 7.99–8.01 (m, 1H), 7.64 (s, 1H), 7.34–7.39 (m, 2H), 7.21 (dd, <i>J</i> = 5.1, 1.8, 1H), 6.96–7.03 (m, 2H), 3.93 (s, 3H), 3.92 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz), δ 165.2, 162.3 (d, <i>J</i><sub>F–C</sub> = 248.1), 149.4, 148.2, 147.7, 141.9, 130.4, 129.7 (d, <i>J</i><sub>F–C</sub> = 8.1), 128.2 (d, <i>J</i><sub>F–C</sub> = 3.7), 124.8, 123.2, 116.7, 115.1 (d, <i>J</i><sub>F–C</sub> = 21.4), 52.4, 38.8. HRMS: calcd for C<sub>17</sub>H<sub>14</sub>FN<sub>3</sub>O<sub>2</sub> 312.1143 (M + H)<sup>+</sup>, found 312.1148.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (4-(3-(4-Fluorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-2-yl)methanol (<b>3</b>)</h3><div class="NLM_p last">To a solution of ester <b>18</b> (180 mg, 0.57 mmol) in THF (6 mL) at rt was added dropwise a THF solution of LAH (1.0 M, 0.86 mL, 0.86 mmol). After 30 min of stirring, the reaction was quenched with dropwise addition of water and diluted with THF (50 mL). After the addition of Celite, the slurry was stirred for 30 min and then filtered through a pad of MgSO<sub>4</sub>. The filtrate was concentrated under reduced pressure to recover 165 mg of desired alcohol as a pink colored gum. This was subjected to silica gel chromatography using 5:95:0.1 MeOH:EtOAc:NH<sub>4</sub>OH (concd) to afford 41 mg (25%) of the title compound as a colorless gum which solidified upon standing at rt. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.39 (d, <i>J </i>= 5.1, 1H), 7.59 (s, 1H), 7.39–7.44 (m, 2H), 7.16 (s, 1H), 6.99–7.06 (m, 3H), 4.68 (s, 2H), 3.97 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 162.4 (d, <i>J</i><sub>F–C</sub> = 247.4), 159.6, 148.6, 148.5, 141.8, 130.7, 128.3 (d, <i>J</i><sub>F–C</sub> = 8.1), 126.2 (d, <i>J</i><sub>F–C</sub> = 2.9), 121.3, 119.2, 117.9, 114.3 (d, <i>J</i><sub>F–C</sub> = 21.4), 64.2, 39.1. HRMS: calcd for C<sub>16</sub>H<sub>14</sub>FN<sub>3</sub>O 284.1194 (M + H)<sup>+</sup>, found 284.1188.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 3-(4-Fluorophenyl)-1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (<b>21</b>)</h3><div class="NLM_p last">To a solution of <i>n</i>-BuLi (2.5 M in hexanes, 500 mL, 1.25 mol) at −70 °C was added slowly a solution of commercially available pyrazole <b>19</b> (160 g, 0.63 mol) in THF (1.2L). The resulting solution was stirred at this temperature for 1 h. 2-Isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane <b>20</b> (175 g, 0.94 mol) was then added slowly to maintain the temperature below −60 °C. After the addition, the reaction was stirred at −70 °C for 30 min and then quenched slowly by the addition of H<sub>2</sub>O. The resulting slurry was filtered off and the filtrate was concentrated under reduced pressure. This was taken up in EtOAc (2L) and washed with (250 mL) and brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to yield crude product which solidified upon cooling to 0 °C. After triturating with 500 mL of hexanes, 84 g (44%) of the title compound was obtained as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.91–7.97 (m, 2H), 7.72 (s, 1H), 7.03–7.09 (m, 2H), 3.91 (s, 3H), 1.31 (s, 12H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 158.8 (d, <i>J</i><sub>F–C</sub> = 245.9), 156.0, 139.8, 129.7 (d, <i>J</i><sub>F–C</sub> = 3.7), 127.7 (d, <i>J</i><sub>F–C</sub> = 8.1), 113.0 (d, <i>J</i><sub>F–C</sub> = 21.4), 99.7, 83.3, 38.6, 24.7. HRMS: calcd for C<sub>16</sub>H<sub>20</sub>BFN<sub>2</sub>O<sub>2</sub> 303.1678 (M + H)<sup>+</sup>, found 303.1672</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 3-Fluoro-4-(3-(4-fluorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)picolinonitrile (<b>23</b>)</h3><div class="NLM_p last">Commercially available 3-fluoro-4-iodopicolinonitrile <b>22</b> (50g, 0.20 mol), 3-(4-boronate <b>21</b> (67 g, 0.22 mol), Pd(OAc)<sub>2</sub> (0.91 g, 4.0 mmol), 2-dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl (Xphos) (3.8 g, 8.0 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (79 g, 0.24 mol) in ACN (350 mL) and H<sub>2</sub>O (70 mL) were refluxed for 3 h under N<sub>2</sub>. The reaction was cooled to rt and filtered and the filtrate was diluted with 300 mL of EtOAc. The organic layer was washed with water (200 mL) and brine (150 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to afford crude product. This was washed with 1:1 EtOAc/hexanes (200 mL) to yield 48 g (80%) of the title compound as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.30 (d, <i>J </i>= 4.9, 1H), 7.87 (d, <i>J </i>= 2.9, 1H), 7.40–7.45 (m, 2H), 7.26–7.30 (m, 1H), 7.08–7.15 (m, 2H), 4.05 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 163.8 (d, <i>J</i><sub>F–C</sub> = 248.9), 158.5 (d, <i>J</i><sub>F–C</sub> = 268.7), 149.9, 146.6 (d, <i>J</i><sub>F–C</sub> = 5.9), 132.7 (d, <i>J</i><sub>F–C</sub> = 7.4), 130.7 (d, <i>J</i><sub>F–C</sub> = 7.4), 130.2 (d, <i>J</i><sub>F–C</sub> = 7.4), 128.4 (d, <i>J</i><sub>F–C</sub> = 3.7), 127.4 (d, <i>J</i><sub>F–C</sub> = 2.2), 123.3 (d, <i>J</i><sub>F–C</sub> = 16.9), 115.9 (d, <i>J</i><sub>F–C</sub> = 22.1), 113.1 (d, <i>J</i><sub>F–C</sub> = 4.4), 108.7, 39.4. HRMS: calcd for C<sub>16</sub>H<sub>10</sub>F<sub>2</sub>N<sub>4</sub> 297.0946 (M + H)<sup>+</sup>, found 297.0941</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>tert</i>-Butyl (2-((2-Cyano-4-(3-(4-fluorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)oxy)ethyl)carbamate (<b>25</b>)</h3><div class="NLM_p last">To <b>23</b> (1.00 g, 3.38 mmol) and <i>tert</i>-butyl (2-hydroxyethyl)carbamate <b>24</b> (777 mg, 4.82 mmol) in THF (17 mL) at −20 °C was added sodium hydride (228 mg, 5.70 mmol). The mixture was stirred for 3.5 h and the bath temperature was kept between −20 and −10 °C. The mixture was warmed to −5 °C for another 20 min and was then quenched with satd ammonium chloride (5 mL). Water (10 mL) was added and the mixture was extracted with 2 × 15 mL of EtOAc. Extracts were washed with brine, dried with MgSO<sub>4</sub>, filtered, and concentrated to give a pale orange oil. The oil was diluted with 2 mL of ethyl acetate, and with stirring, an equal volume of isooctane was added, resulting in a thick slurry. This was stirred overnight and the title compound (1.03 g, 70%) was isolated by filtration as a white powder. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.22 (d, <i>J </i>= 4.9, 1H), 7.80 (s, 1H), 7.32–7.37 (m, 2H), 7.19 (d, <i>J</i> = 4.9, 1H), 6.96–7.03 (m, 2H), 5.02 (br s, 1H), 3.99 (s, 3H), 3.96 (t, <i>J</i> = 5.1, 2H), 3.35 (dd, <i>J</i> = 5.3, 5.3, 2H), 1.38 (s, 9H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 162.2 (d, <i>J</i><sub>F–C</sub> = 248.1), 155.5, 155.4, 148.6, 145.7, 135.6, 131.9, 129.2 (d, <i>J</i><sub>F–C</sub> = 8.1), 128.4, 128.2 (d, <i>J</i><sub>F–C</sub> = 2.9), 128.0, 115.3 (d, <i>J</i><sub>F–C</sub> = 22.1), 115.1, 110.9, 79.1, 73.4, 40.1, 38.9, 27.9. HRMS: calcd for C<sub>23</sub>H<sub>24</sub>FN<sub>5</sub>O<sub>3</sub> 438.1941 (M + H)<sup>+</sup>, found 438.1936.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 9-(3-(4-Fluorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)-3,4-dihydropyrido[2,3-<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one (<b>27</b>)</h3><div class="NLM_p last">To 7 mL of neat sulfuric acid was added with stirring carbamate <b>25</b> (2.00 g, 4.58 mmol). The mixture was heated to 110 °C for 10 min and then cooled to rt. The solution was then added slowly to ∼30 mL of crushed ice and water and cooled to −10 °C. To the cold mixture was added slowly 5 N NaOH (45 mL) to bring the pH near neutral, followed by 1 M pH 7 phosphate buffer to achieve a final pH of 7. The mixture was heated back to 110 °C for 3 h and then was cooled to rt and stirred for 12 h. The tan solids were collected via filtration and recrystallized from ethyl acetate/methanol (95:5) to yield 1.3 g (80%) of the title compound as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 8.52 (t, <i>J </i>= 6.0, 1H), 8.31 (d, <i>J</i> = 4.7, 1H), 8.01 (s, 1H), 7.34–7.40 (m, 2H), 7.14–7.23 (m, 3H), 3.94 (s, 3H), 3.89 (t, <i>J</i> = 5.3, 2H), 3.20 (dd, <i>J</i> = 5.3, 10.9, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz): δ 167.86, 161.8 (d, <i>J</i><sub>F–C</sub> = 244.4), 148.0, 147.6, 146.8, 144.9, 135.5, 133.1, 130.0 (d, <i>J</i><sub>F–C</sub> = 3.7), 129.5 (d, <i>J</i><sub>F–C</sub> = 8.1), 127.3, 115.6 (d, <i>J</i><sub>F–C</sub> = 22.1), 112.4, 74.6, 39.0, 38.5. HRMS: calcd for C<sub>18</sub>H<sub>15</sub>FN<sub>4</sub>O<sub>2</sub> 339.1179 (M + H)<sup>+</sup>, found 339.1251.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 9-(3-(4-Fluorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)-2,3,4,5-tetrahydropyrido[2,3-<i>f</i>][1,4]oxazepine (<b>5</b>)</h3><div class="NLM_p last">Oxazepinone <b>27</b> (300 mg, 0.89 mmol) was added in 50 mg increments over 10 min to a 50 °C solution of LAH (1 M in THF, 1.5 mL, 1.5 mmol) in THF (50 mL). The mixture was stirred at 50 °C for 1 h. An additional 0.5 mL of the lithium aluminum hydride solution was added and the mixture stirred at 50 °C for an additional hour. The mixture was cooled to rt and quenched by the sequential addition of 0.1 mL of water, 0.1 mL of 15% NaOH, and 0.3 mL of water. The mixture was stirred at rt for 4 days and then was filtered through a bed of Celite. The filter cake was rinsed with THF (20 mL) and EtOAc (20 mL). The combined filtrate was treated with decolorizing carbon, filtered, and concentrated to yield 234 mg of a pale yellow solid. This was dissolved in EtOAc (20 mL) and treated with <i>p</i>-toluenesulfonic acid (285 mg, 1.50 mmol) as a solution in 1 mL of methanol. An additional 0.5 mL of methanol was added with gentle warming while a precipitate began to appear. The mixture was stirred at rt for 12 h, at which point the solids were collected via filtration to provide 280 mg (42%) of the title compound as a pale yellow solid. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>, 400 MHz): δ 8.38 (d, <i>J</i> = 5.9, 1H), 8.35 (s, 1H), 7.63 (d, <i>J</i> = 6.3, 1H), 7.46–7.51 (m, 2H), 7.15–7.22 (m, 2H), 4.87 (s, 2H), 4.44–4.48 (m, 2H), 4.04 (s, 3H), 3.78–3.82 (m, 2H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>, 100 MHz): δ 164.8(d, <i>J</i><sub>F–C</sub> = 247.4), 156.2, 152.5, 145.5, 141.7, 138.9, 137.2, 135.5 (d, <i>J</i><sub>F–C</sub> = 8.1), 129.3 (d, <i>J</i><sub>F–C</sub> = 3.0), 128.4, 115.9 (d, <i>J</i><sub>F–C</sub> = 22.1), 112.4, 70.5, 50.3, 48.0, 40.1. HRMS: calcd for C<sub>18</sub>H<sub>17</sub>FN<sub>4</sub>O 325.1459 (M + H)<sup>+</sup>, found 325.1454.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-Bromo-4-(3-(4-fluorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)pyridine (<b>29</b>)</h3><div class="NLM_p last">To a DMF (5 mL) solution of commercially available <b>28</b> (0.095 g, 0.34 mmol), boronate <b>21</b> (0.100 g, 0.335 mmol), and cesium fluoride (0.106 g, 0.67 mmol) under N<sub>2</sub> was added [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) (13 mg, 0.017 mmol). The mixture was heated to 140 °C for 2 h and then cooled to rt. The reaction was diluted with EtOAc (100 mL), filtered through a pad of Celite, and rinsed with another 10 mL of EtOAc. The filtrate was washed with H<sub>2</sub>O (20 mL) and brine (15 mL), dried over MgSO<sub>4</sub>, and filtered. The filtrate was concentrated under reduced pressure to recover a residual oil. This was subjected to silica gel chromatography using 60% EtOAc/heptanes to recover 100 mg of solid. Crystallization from hot EtOAc/heptanes yielded 89 mg of the title compound as a white solid (80% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.22 (d, <i>J</i> = 5.3, 1H), 7.62 (s, 1H), 7.41–7.45 (m, 2H), 7.39 (m, 1H), 7.06 −7.10 (m, 3H), 3.99 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 162.8 (<i>J</i><sub>F–C</sub> = 247.4), 150.0, 148.7, 143.8, 142.6, 130.8, 130.2 (<i>J</i><sub>F–C</sub> = 8.1), 128.5 (<i>J</i><sub>F–C</sub> = 2.9), 126.2, 121.5, 116.6, 115.6 (<i>J</i><sub>F–C</sub> = 21.4), 39.2. HRMS: calcd for C<sub>15</sub>H<sub>11</sub>BrFN<sub>3</sub> 332.0193 (M + H)<sup>+</sup>, found 332.0197.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>tert</i>-Butyl (2-(2-(4-(3-(4-Fluorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-2-yl)-2-oxoethoxy)ethyl)carbamate (<b>31</b>)</h3><div class="NLM_p last">A suspension of <b>29</b> (10.0 g, 30.0 mmol) in toluene (300 mL) in a three-necked flask fitted with a nitrogen inlet and a mechanical stirrer was cooled to −78 °C. <i>n</i>-BuLi (2.5 M in hexanes,12.0 mL, 30.0 mmol) was added at such a rate to maintain the internal temperature below −72 °C. The reaction was then stirred at −78 °C for 30 min and a solution of <i>tert</i>-butyl 3-oxomorpholine-4-carboxylate (6.1 g, 30.1 mmol) in toluene (50 mL) was added dropwise to keep the temperature below −70 °C. The reaction was stirred at −78 °C for 1 h, warmed to rt, stirred for 2 h, and quenched with a mixture of saturated NH<sub>4</sub>Cl/EtOAc (1:5, 600 mL). The organic phase was dried (MgSO<sub>4</sub>) and evaporated to dryness in vacuo and the residue purified by flash chromatography using a 0–100% gradient of ethyl acetate in heptane to yield 3.0 g (22%) of title compound as an off-white foam. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.40 (d, <i>J</i> = 5.1, 1H), 7.93 (d, <i>J</i> = 1.6, 1H), 7.66 (s, 1H), 7.34–7.39 (m, 2H), 7.22 (dd, <i>J</i> = 1.9, 5.1, 1H), 6.98–7.03 (m, 2H), 5.26 (br s, 1H), 5.05 (s, 2H), 3.95 (s, 3H), 3.64 (dd, <i>J</i> = 4.7, 10.2, 2H), 3.36 (dd, <i>J</i> = 5.1, 10.2, 2H), 1.41 (s, 9H). <sup>13</sup>C NMR (CDCl<sub>3</sub>,100 MHz): δ 197.5, 171.4, 163.2 (<i>J</i><sub>F–C</sub> = 248.1), 156.3, 152.6, 149.4, 149.1, 142.6, 131.2, 130.5 (<i>J</i><sub>F–C</sub> = 8.1), 129.0 (<i>J</i><sub>F–C</sub> = 2.9), 126.4, 120.4, 117.6, 116.0 (<i>J</i><sub>F–C</sub> = 22.1), 74.0, 71.1, 40.7, 39.6, 28.7. LCMS: <i>m</i>/<i>z</i> 399 (M + H – <i>t</i>-Bu).</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 5-(4-(3-(4-Fluorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-2-yl)-3,6-dihydro-2<i>H</i>-1,4-oxazine (<b>32</b>)</h3><div class="NLM_p last">A solution of carbamate <b>31</b> (3.0 g, 6.6 mmol) in ethanol was treated with 1.0 M HCl in ethanol (60.0 mL, 60.0 mmol), and the mixture was stirred at rt for 12 h and concentrated under high pressure to give title compound (3.0 g, >100%). This crude imine was used without further purification in the next step. LCMS: <i>m</i>/<i>z</i> 337 (M + H).</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (−)-3-(4-(3-(4-Fluorophenyl)-1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-2-yl)morpholine (<b>6</b>)</h3><div class="NLM_p">A solution of <b>32</b> (2.7 g, 8.0 mmol) in methanol (20 mL) was cooled to −40 °C, NaBH<sub>4</sub> (1.2 g, 32.0 mmol) was added in batches, and the mixture was stirred at rt for 30 min. The mixture was diluted with DCM (150 mL) and washed with water and brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo. The residue was purified by flash chromatography eluting with EtOAc, 10% EtOAc/EtOAc, and 10% MeOH/DCM to yield 0.5 g (26%) of racemic title compound as a colorless foam. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.37 (d, <i>J</i> = 5.1, 1H), 7.58 (s, 1H), 7.37–7.41 (m, 2H), 7.20–7.25 (m, 1H), 6.98–7.04 (m, 3H), 3.96 (s, 3H), 3.93–4.00 (m, 2H), 3.86–3.89 (m, 1H), 3.51–3.58 (m, 1H), 3.39–3.45 (m, 1H), 3.04–3.11 (m, 1H), 2.95–3.0 (m, 1H). LCMS: <i>m</i>/<i>z</i> 339 (M + H).</div><div class="NLM_p">Chiral HPLC (Chiralcel OJ-H, 10/90 MeOH/CO<sub>2</sub> with 0.2% isopropylamine) was used to separate the enantiomers. Enantiomer 1, title compound <b>6</b>: [α]<sub class="stack">D</sub><sup class="stack">25</sup> = −29.5 (<i>c</i> = 1.0, MeOH). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 8.42 (d, <i>J</i> = 5.1, 1H), 7.60 (s, 1H), 7.37–7.45 (m, 2H), 7.22 (s, 1H), 6.99–7.07 (m, 3H), 3.95–4.02 (m, 2 H), 3.97 (s, 3H), 3.85 (dd, <i>J</i> = 1.5, 11.2, 1H), 3.53–3.61 (m, 1 H), 3.41–3.46 (m, 1H), 3.07–3.14 (m, 1H), 2.97–3.02 (m, 1 H), 2.2 (br s, 1 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ 162.4 (d, <i>J</i><sub>F–C</sub> = 247.4), 159.5, 149.5, 148.5, 141.5, 130.6, 130.1 (<i>J</i><sub>F–C</sub> = 8.1), 128.9 (<i>J</i><sub>F–C</sub> = 3.7), 121.4, 120.3, 118.0, 115.5 (<i>J</i><sub>F–C</sub> = 21.4), 72.2, 67.4, 60.3, 45.7, 39.1. HRMS: calcd for C<sub>19</sub>H<sub>19</sub>FN<sub>4</sub>O 339.1616 (M + H), found 339.1618 (M + H). Enantiomer 2: [α]<sub class="stack">D</sub><sup class="stack">24</sup> = 34.7 (<i>c</i> = 1.0, MeOH).</div><div id="sec4_21_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Biology</h4><div id="sec4_21_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> Cell Free (Biochemical Assay)</h5><div class="NLM_p last">The CK1δ and CK1ε kinase assays were performed in a 20 μL final volume in buffer containing 50 mM Tris, pH 7.5, 10 mM MgCl<sub>2</sub>, 1 mM DTT, 100 μg/mL BSA, 1 mM TCEP, 1.25% glycerol, 0.0125% P104, 2.5 mM KCl, 10 μM ATP, and 42 μM peptide substrate PLSRTLpSVASLPGL.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The final enzyme concentrations were 2 nM for CK1δ and 2.5 nM for Ck1ε. Assays were run in a panel format in the presence of 1 μL of compounds or 4% DMSO. The reactions were incubated for 60 min at 25 °C for CK1δ and 85 min at 25 °C for CK1ε, followed by detection with use of 20 μL of Kinase-Glo Plus Assay reagent according to the manufacturer’s instructions. Luminescent output was measured on the Perkin-Elmer Envision plate reader.</div></div><div id="sec4_21_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> Whole Cell (Translocation Assay)</h5><div class="NLM_p last">COS-7 cells were maintained at 37 °C in 5% CO<sub>2</sub> in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum. Log-phase cells were dislodged with 5 min treatment with TrypLE Express, and viable cell count was determined with a Cedex cell counter. Cells were diluted in DMEM medium to a density of 1.5 × 10<sup>5</sup> viable cells/mL in two-thirds of the final volume of final transfected cell mix. Cells were cotransfected with two plasmid DNAs, mPER3-GFP in pd2EGFP-N1 vector and human CK1 in pcDNA4/hisA vector (for CK1ε at a ratio of 1:5 respectively for CK1δ at a ratio of 1:11 respectively), using Lipofectamine 2000 reagent according to the manufacturer’s recommendations. The transfection mix contained approximately 0.83 μg/mL of DNA and 6 μL/mL of Lipofectamine 2000, in a total of one-third of the final transfection volume in Opti-MEM medium. After 20 min at room temperature, the cell mix was combined with the DNA transfection mix, per manufacturer instructions. Transfected cell suspension (50 mL) was dispensed per well by multidrop dispenser into Greiner 384-well Cellcoat (PDL) plates. Compounds were diluted with Opti-MEM I to a 4× concentration before addition to plated cells. Inhibitors of CKIδ/ε were tested at 11 concentrations to evaluate their ability to inhibit mPER3-GFP translocation to the nucleus. After overnight exposure at 37 °C in a CO<sub>2</sub> incubator, cells were fixed by the addition of 12% paraformaldehyde in phosphate-buffered saline (PBS) with 20% sucrose to a final concentration of 4%, and then the cells were incubated for 30 min at room temperature. Fixative was removed, and cells were washed with PBS and then stained with 0.4 μg/mL Hoechst dye in blocking buffer containing 4% goat serum and 0.1% TritonX for 1 h. In some experiments, GFP enhancing antibodies were used when needed for signal amplification. Cells were washed again with PBS and stored at 4 °C in PBS or scanned immediately with the Cellomics ArrayScan VTI.</div></div><div id="sec4_21_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> Circadian Timing</h5><div class="NLM_p last">Methods follow those procedures published previously.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> All procedures performed on these animals were in accordance with regulations and established guidelines and were reviewed and approved by an Institutional Animal Care and Use Committee or through an ethical review process.</div></div><div id="sec4_21_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> P38 in Vitro Activity Assay and Kinase Panel</h5><div class="NLM_p last">Compounds were tested at 1 μM with use of Invitrogen SelectScreen Kinase Profiling. All kinases were tested at their <i>K</i><sub>m</sub> for ATP. Values of P38 IC<sub>50</sub> were also determined at Invitrogen for select compounds.</div></div><div id="sec4_21_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> Pharmacokinetic Characterization</h5><div class="NLM_p">The single point concentration values for all compounds in plasma and whole brain were determined in male C57BL/6J mice after administration of a single subcutaneous dose. Plasma and whole brains were collected from mice while they were receiving isoflurane treatment at 0.5, 1, 2, 4, 8, and 24 h after dosing (<i>n</i> = 4 per time point). Plasma was obtained after centrifugation of whole blood. Whole brains were diluted in a 4× volume (w/v) 60% isopropyl alcohol and homogenized by use of a Mini-Beadbeater 96 (Biospec Products, Bartlesville, OK). Both plasma and brain homogenate samples were quantified with use of a liquid chromatography–mass spectrometry method following protein precipitation. Concentration and pharmacokinetic results are presented as mean ± SEM. AUC<sub>0</sub>–<i>T</i><sub>last</sub> values were calculated with use of the linear trapezoidal rule.</div><div class="NLM_p last">Protein binding experiments were conducted with mouse plasma and brain homogenate with use of high-throughput 96-well equilibrium dialysis.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Aliquots (<i>n</i> = 6 per matrix) of plasma and brain homogenate spiked with 1 μM compound were dialyzed against an equal volume of buffer for 6 h at 37 °C. The dialysis membranes had a molecular cutoff of 12–14 kDa (Spectrum Laboratories Inc., Rancho Dominguez, CA). After incubation, donor and receiver samples were transferred to a 96-well block containing an equal volume of the opposite matrix and internal standard. The diluted samples were then analyzed by liquid chromatography/mass spectrometry after protein precipitation. Free fraction in plasma was calculated as the ratio of instrument response between donor and receiver samples. Determination of undiluted brain-free fraction was calculated as described previously.</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">All coordinates have been deposited in the PDB with accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KBC">4KBC</a> (<b>3</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KB8">4KB8</a> (<b>4</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KBA">4KBA</a> (<b>5</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KBK">4KBK</a> (<b>6</b>).</p><div class="testing" data-doi="10.1021/jm4006324" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51537" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51537" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scot Mente</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7506161a015b18101b01103505131c0f10075b161a18"><span class="__cf_email__" data-cfemail="d4a7b7bba0fab9b1baa0b194a4b2bdaeb1a6fab7bbb9">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Arnold</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Todd Butler</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Subramanyam Chakrapani</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramalakshmi Chandrasekaran</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Cherry</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ken DiRico</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela Doran</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katherine Fisher</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Galatsis</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Green</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew Hayward</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Humphrey</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Knafels</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianke Li</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shenping Liu</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Marconi</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott McDonald</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeff Ohren</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vanessa Paradis</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Blossom Sneed</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Walton</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Travis Wager</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide Research
and Development, 700
Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2684e2745-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26770" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26770" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Greg Kauffman for helpful discussions and careful editing of this manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i41" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i41"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i42" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i42"> Abbreviations Used</h2><tr><td class="NLM_term">CK1δ</td><td class="NLM_def"><p class="first last">casien kinase 1δ</p></td></tr><tr><td class="NLM_term">CK1ε</td><td class="NLM_def"><p class="first last">casien kinase 1ε</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">MPO</td><td class="NLM_def"><p class="first last">multiparameter optimization</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">protein data bank</p></td></tr><tr><td class="NLM_term">p38</td><td class="NLM_def"><p class="first last">p38 mitogen-activated kinase</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption</p></td></tr><tr><td class="NLM_term">distribution</td><td class="NLM_def"><p class="first last">metabolism and excretion.</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01886" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01886" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Price, M. A.</span><span> </span><span class="NLM_article-title">CKI, there’s more than one: Casein kinase I family members in Wnt and hedgehog signaling</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=399-410&author=M.+A.+Price&title=CKI%2C+there%E2%80%99s+more+than+one%3A+Casein+kinase+I+family+members+in+Wnt+and+hedgehog+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DM.%2BA.%26atitle%3DCKI%252C%2520there%25E2%2580%2599s%2520more%2520than%2520one%253A%2520Casein%2520kinase%2520I%2520family%2520members%2520in%2520Wnt%2520and%2520hedgehog%2520signaling%26jtitle%3DGenes%2520Dev.%26date%3D2006%26volume%3D20%26spage%3D399%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Gallego, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virshup, D. M.</span><span> </span><span class="NLM_article-title">Post-translational modifications regulate the ticking of the circadian clock</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1038%2Fnrm2106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=17245414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFKlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=139-148&author=M.+Gallegoauthor=D.+M.+Virshup&title=Post-translational+modifications+regulate+the+ticking+of+the+circadian+clock"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Post-translational modifications regulate the ticking of the circadian clock</span></div><div class="casAuthors">Gallego, Monica; Virshup, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-148</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Getting a good night's sleep is on everyone's to-do list.  So is, no doubt, staying awake during late afternoon seminars.  Our internal clocks control these and many more workings of the body, and disruptions of the circadian clocks predispose individuals to depression, obesity and cancer.  Mutations in kinases and phosphatases in hamsters, flies, fungi and humans highlight how our timepieces are regulated and provide clues as to how we might be able to manipulate them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriwqkvC7R2HbVg90H21EOLACvtfcHk0lj6AlvK9ZP3UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFKlsg%253D%253D&md5=60be65c47ffadcc453b2f7257adbc511</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrm2106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2106%26sid%3Dliteratum%253Aachs%26aulast%3DGallego%26aufirst%3DM.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26atitle%3DPost-translational%2520modifications%2520regulate%2520the%2520ticking%2520of%2520the%2520circadian%2520clock%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D139%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Knippschild, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gocht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löhler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stöter, M.</span><span> </span><span class="NLM_article-title">The casein kinase 1 family: Participation in multiple cellular processes in eukaryotes</span> <span class="citation_source-journal">Cell. Signal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">689</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1016%2Fj.cellsig.2004.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=15722192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslWltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=675-689&author=U.+Knippschildauthor=A.+Gochtauthor=S.+Wolffauthor=N.+Huberauthor=J.+L%C3%B6hlerauthor=M.+St%C3%B6ter&title=The+casein+kinase+1+family%3A+Participation+in+multiple+cellular+processes+in+eukaryotes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The casein kinase 1 family: participation in multiple cellular processes in eukaryotes</span></div><div class="casAuthors">Knippschild, Uwe; Gocht, Andreas; Wolff, Sonja; Huber, Nadine; Loehler, Juergen; Stoeter, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">675-689</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Phosphorylation of Ser, Thr, and Tyr residues by cellular protein kinases plays an important role in the regulation of various cellular processes.  The Ser/Thr-specific casein kinase 1 and 2 protein kinase families, CK1 and CK2, resp., were among the 1st protein kinases that had been described.  In recent years, knowledge of the regulation and function of mammalian CK1 kinase family members has rapidly increased.  Extracellular stimuli, the subcellular localization of CK1 isoforms, their interaction with various cellular structures and proteins, as well as autophosphorylation and proteolytic cleavage of their C-terminal regulatory domains influence CK1 kinase activity.  Mammalian CK1 isoforms phosphorylate many different substrates, among them key regulatory proteins involved in the control of cell differentiation, proliferation, chromosome segregation, and circadian rhythms.  De-regulation and/or the incidence of mutations in the coding sequence of CK1 isoforms have been linked to neurodegenerative diseases and cancer.  Here, the authors summarize the current knowledge about the function and regulation of mammalian CK1 isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYTGvFy5TMyLVg90H21EOLACvtfcHk0lj6AlvK9ZP3UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslWltb4%253D&md5=e44cbddc335887723b171bf889dd2f08</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2004.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2004.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnippschild%26aufirst%3DU.%26aulast%3DGocht%26aufirst%3DA.%26aulast%3DWolff%26aufirst%3DS.%26aulast%3DHuber%26aufirst%3DN.%26aulast%3DL%25C3%25B6hler%26aufirst%3DJ.%26aulast%3DSt%25C3%25B6ter%26aufirst%3DM.%26atitle%3DThe%2520casein%2520kinase%25201%2520family%253A%2520Participation%2520in%2520multiple%2520cellular%2520processes%2520in%2520eukaryotes%26jtitle%3DCell.%2520Signal.%26date%3D2005%26volume%3D17%26spage%3D675%26epage%3D689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Galatsis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offord, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMarco, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohren, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mente, S.</span><span> </span><span class="NLM_article-title">Chapter 3—Central modulation of circadian rhythm via CK1 inhibition for psychiatric indications</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=33-51&author=P.+Galatsisauthor=T.+T.+Wagerauthor=J.+Offordauthor=G.+J.+DeMarcoauthor=J.+F.+Ohrenauthor=I.+Efremovauthor=S.+Mente&title=Chapter+3%E2%80%94Central+modulation+of+circadian+rhythm+via+CK1+inhibition+for+psychiatric+indications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalatsis%26aufirst%3DP.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DOfford%26aufirst%3DJ.%26aulast%3DDeMarco%26aufirst%3DG.%2BJ.%26aulast%3DOhren%26aufirst%3DJ.%2BF.%26aulast%3DEfremov%26aufirst%3DI.%26aulast%3DMente%26aufirst%3DS.%26atitle%3DChapter%25203%25E2%2580%2594Central%2520modulation%2520of%2520circadian%2520rhythm%2520via%2520CK1%2520inhibition%2520for%2520psychiatric%2520indications%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D33%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Badura, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamowicz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianfrogna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Germain, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprouse, J.</span><span> </span><span class="NLM_article-title">An inhibitor of casein kinase Iε induces phase delays in circadian rhythms under free-running and entrained conditions</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1124%2Fjpet.107.122846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=17502429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslSjuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2007&pages=730-738&author=L.+Baduraauthor=T.+Swansonauthor=W.+Adamowiczauthor=J.+Adamsauthor=J.+Cianfrognaauthor=K.+Fisherauthor=J.+Hollandauthor=R.+Kleimanauthor=F.+Nelsonauthor=L.+Reynoldsauthor=K.+St.+Germainauthor=E.+Schaefferauthor=B.+Tateauthor=J.+Sprouse&title=An+inhibitor+of+casein+kinase+I%CE%B5+induces+phase+delays+in+circadian+rhythms+under+free-running+and+entrained+conditions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">An inhibitor of casein kinase Iε induces phase delays in circadian rhythms under free-running and entrained conditions</span></div><div class="casAuthors">Badura, Lori; Swanson, Terri; Adamowicz, Wendy; Adams, Jessica; Cianfrogna, Julie; Fisher, Katherine; Holland, Janice; Kleiman, Robin; Nelson, Frederick; Reynolds, Linda; St. Germain, Kristin; Schaeffer, Eric; Tate, Barbara; Sprouse, Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">730-738</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Casein kinase Iε (CKIε) is an essential component of the biol. clock, phosphorylating PER proteins, and in doing so regulating their turnover and nuclear entry in oscillator cells of the suprachiasmatic nucleus (SCN).  Although hereditary decreases in PER phosphorylation have been well characterized, little is known about the consequences of acute enzyme inhibition by pharmacol. means.  A novel reagent, 4-[3-cyclohexyl-5-(4-fluoro-phenyl)-3H-imidazol-4-yl]-pyrimidin-2-ylamine (PF-670462), proved to be both a potent (IC50 = 7.7 ± 2.2 nM) and selective (>30-fold with respect to 42 addnl. kinases) inhibitor of CKIε in isolated enzyme prepns.; in transfected whole cell assays, it caused a concn.-related redistribution of nuclear vs. cytosolic PER.  When tested in free-running animals, 50 mg/kg s.c. PF-670462 produced robust phase delays when dosed at circadian time (CT)9 (-1.97 ± 0.17 h).  Entrained rats dosed in normal light-dark (LD) and then released to const. darkness also experienced phase delays that were dose- and time of dosing-dependent.  PF-670462 yielded only phase delays across the circadian cycle with the most sensitive time at CT12 when PER levels are near their peak in the SCN.  Most importantly, these drug-induced phase delays persisted in animals entrained and maintained in LD throughout the entire expt.; re-entrainment to the prevailing LD required days in contrast to the rapid elimination of the drug (t1/2 = 0.46 ± 0.04 h).  Together, these results suggest that inhibition of CKIε yields a perturbation of oscillator function that forestalls light as a zeitgeber, and they demonstrate that pharmacol. tools such as PF-670462 may yield valuable insight into clock function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfqMEeisE8I7Vg90H21EOLACvtfcHk0ljzkYYOQvHUZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslSjuro%253D&md5=ec355b6d0cee0f1ad9d37cad55f0936d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.122846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.122846%26sid%3Dliteratum%253Aachs%26aulast%3DBadura%26aufirst%3DL.%26aulast%3DSwanson%26aufirst%3DT.%26aulast%3DAdamowicz%26aufirst%3DW.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DK.%26aulast%3DHolland%26aufirst%3DJ.%26aulast%3DKleiman%26aufirst%3DR.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DReynolds%26aufirst%3DL.%26aulast%3DSt.%2BGermain%26aufirst%3DK.%26aulast%3DSchaeffer%26aufirst%3DE.%26aulast%3DTate%26aufirst%3DB.%26aulast%3DSprouse%26aufirst%3DJ.%26atitle%3DAn%2520inhibitor%2520of%2520casein%2520kinase%2520I%25CE%25B5%2520induces%2520phase%2520delays%2520in%2520circadian%2520rhythms%2520under%2520free-running%2520and%2520entrained%2520conditions%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D322%26spage%3D730%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Walton, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubitski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, Q.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sladek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamohan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serpa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claffey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastings, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loudon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maywood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span> </span><span class="NLM_article-title">Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock period</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1124%2Fjpet.109.151415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=19458106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFClsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2009&pages=430-439&author=K.+M.+Waltonauthor=K.+Fisherauthor=D.+Rubitskiauthor=M.+Marconiauthor=Q.-J.+Mengauthor=M.+Sladekauthor=J.+Adamsauthor=M.+Bassauthor=R.+Chandrasekaranauthor=T.+Butlerauthor=M.+Grifforauthor=F.+Rajamohanauthor=M.+Serpaauthor=Y.+Chenauthor=M.+Claffeyauthor=M.+Hastingsauthor=A.+Loudonauthor=E.+Maywoodauthor=J.+Ohrenauthor=A.+Doranauthor=T.+T.+Wager&title=Selective+inhibition+of+casein+kinase+1+epsilon+minimally+alters+circadian+clock+period"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of casein kinase 1ε minimally alters circadian clock period</span></div><div class="casAuthors">Walton, Kevin M.; Fisher, Katherine; Rubitski, David; Marconi, Michael; Meng, Qing-Jun; Sladek, Martin; Adams, Jessica; Bass, Michael; Chandrasekaran, Rama; Butler, Todd; Griffor, Matt; Rajamohan, Francis; Serpa, Megan; Chen, Yuhpyng; Claffey, Michelle; Hastings, Michael; Loudon, Andrew; Maywood, Elizabeth; Ohren, Jeffrey; Doran, Angela; Wager, Travis T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">430-439</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The circadian clock links our daily cycles of sleep and activity to the external environment.  Deregulation of the clock is implicated in a no. of human disorders, including depression, seasonal affective disorder, and metabolic disorders.  Casein kinase 1 epsilon (CK1ε) and casein kinase 1 delta (CK1δ) are closely related Ser-Thr protein kinases that serve as key clock regulators as demonstrated by mammalian mutations in each that dramatically alter the circadian period.  Therefore, inhibitors of CK1δ/ε may have utility in treating circadian disorders.  Although we previously demonstrated that a pan-CK1δ/ε inhibitor, 4-[3-cyclohexyl-5-(4-fluoro-phenyl)-3H-imidazol-4-yl]-pyrimidin-2-ylamine (PF-670462), causes a significant phase delay in animal models of circadian rhythm, it remains unclear whether one of the kinases has a predominant role in regulating the circadian clock.  To test this, we have characterized 3-(3-chloro-phenoxymethyl)-1-(tetrahydro-pyran-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine (PF-4800567), a novel and potent inhibitor of CK1ε (IC50 = 32 nM) with greater than 20-fold selectivity over CK1δ.  PF-4800567 completely blocks CK1ε-mediated PER3 nuclear localization and PER2 degrdn.  In cycling Rat1 fibroblasts and a mouse model of circadian rhythm, however, PF-4800567 has only a minimal effect on the circadian clock at concns. substantially over its CK1ε IC50.  This is in contrast to the pan-CK1δ/ε inhibitor PF-670462 that robustly alters the circadian clock under similar conditions.  These data indicate that CK1ε is not the predominant mediator of circadian timing relative to CK1δ.  PF-4800567 should prove useful in probing unique roles between these two kinases in multiple signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbn1TWKcCGxrVg90H21EOLACvtfcHk0ljzkYYOQvHUZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFClsL4%253D&md5=2efd448788149e6f563c226bc871f5c3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.151415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.151415%26sid%3Dliteratum%253Aachs%26aulast%3DWalton%26aufirst%3DK.%2BM.%26aulast%3DFisher%26aufirst%3DK.%26aulast%3DRubitski%26aufirst%3DD.%26aulast%3DMarconi%26aufirst%3DM.%26aulast%3DMeng%26aufirst%3DQ.-J.%26aulast%3DSladek%26aufirst%3DM.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DBass%26aufirst%3DM.%26aulast%3DChandrasekaran%26aufirst%3DR.%26aulast%3DButler%26aufirst%3DT.%26aulast%3DGriffor%26aufirst%3DM.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DSerpa%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DClaffey%26aufirst%3DM.%26aulast%3DHastings%26aufirst%3DM.%26aulast%3DLoudon%26aufirst%3DA.%26aulast%3DMaywood%26aufirst%3DE.%26aulast%3DOhren%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%26aulast%3DWager%26aufirst%3DT.%2BT.%26atitle%3DSelective%2520inhibition%2520of%2520casein%2520kinase%25201%2520epsilon%2520minimally%2520alters%2520circadian%2520clock%2520period%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D330%26spage%3D430%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Force, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaja, K. L.</span><span> </span><span class="NLM_article-title">Cardiotoxicity of kinase inhibitors: The prediction and translation of preclinical models to clinical outcomes</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1038%2Fnrd3252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=21283106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlektrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=111-126&author=T.+Forceauthor=K.+L.+Kolaja&title=Cardiotoxicity+of+kinase+inhibitors%3A+The+prediction+and+translation+of+preclinical+models+to+clinical+outcomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes</span></div><div class="casAuthors">Force, Thomas; Kolaja, Kyle L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-126</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Targeted therapeutics, particularly those that inhibit the activity of protein kinases that are mutated and/or overexpressed in cancer, have revolutionized the treatment of some cancers and improved survival rates in many others.  Although these agents dominate drug development in cancer, significant toxicities, including cardiotoxicity, have emerged.  In this Review, we examine the underlying mechanisms that result in on-target or off-target cardiotoxicities of small mol. kinase inhibitors.  We also discuss how well the various preclin. safety models and strategies might predict clin. cardiotoxicity.  It is hoped that a thorough understanding of the mechanisms underlying cardiotoxicity will lead to the development of safe, effective drugs and consequently, fewer costly surprises as agents progress through clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNZMyMbzgEU7Vg90H21EOLACvtfcHk0lgrr7uYhmRVOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlektrg%253D&md5=3528aab655aaac600639929dd8942f63</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd3252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3252%26sid%3Dliteratum%253Aachs%26aulast%3DForce%26aufirst%3DT.%26aulast%3DKolaja%26aufirst%3DK.%2BL.%26atitle%3DCardiotoxicity%2520of%2520kinase%2520inhibitors%253A%2520The%2520prediction%2520and%2520translation%2520of%2520preclinical%2520models%2520to%2520clinical%2520outcomes%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D111%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kerkela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grazette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yacobi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iliescu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patten, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beahm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shevtsov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clubb, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Etten, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alroy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durand, J.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Force, T.</span><span> </span><span class="NLM_article-title">Cardiotoxicity of the cancer therapeutic agent imatinib mesylate</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1038%2Fnm1446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=16862153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A280%3ADC%252BD28rhtlKrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=908-916&author=R.+Kerkelaauthor=L.+Grazetteauthor=R.+Yacobiauthor=C.+Iliescuauthor=R.+Pattenauthor=C.+Beahmauthor=B.+Waltersauthor=S.+Shevtsovauthor=S.+Pesantauthor=F.+J.+Clubbauthor=A.+Rosenzweigauthor=R.+N.+Salomonauthor=R.+A.+Van+Ettenauthor=J.+Alroyauthor=J.-B.+Durandauthor=T.+Force&title=Cardiotoxicity+of+the+cancer+therapeutic+agent+imatinib+mesylate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiotoxicity of the cancer therapeutic agent imatinib mesylate</span></div><div class="casAuthors">Kerkela Risto; Grazette Luanda; Yacobi Rinat; Iliescu Cezar; Patten Richard; Beahm Cara; Walters Brian; Shevtsov Sergei; Pesant Stephanie; Clubb Fred J; Rosenzweig Anthony; Salomon Robert N; Van Etten Richard A; Alroy Joseph; Durand Jean-Bernard; Force Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">908-16</span>
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    </div><div class="casAbstract">Imatinib mesylate (Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia.  Here we report ten individuals who developed severe congestive heart failure while on imatinib and we show that imatinib-treated mice develop left ventricular contractile dysfunction.  Transmission electron micrographs from humans and mice treated with imatinib show mitochondrial abnormalities and accumulation of membrane whorls in both vacuoles and the sarco- (endo-) plasmic reticulum, findings suggestive of a toxic myopathy.  With imatinib treatment, cardiomyocytes in culture show activation of the endoplasmic reticulum (ER) stress response, collapse of the mitochondrial membrane potential, release of cytochrome c into the cytosol, reduction in cellular ATP content and cell death.  Retroviral gene transfer of an imatinib-resistant mutant of c-Abl, alleviation of ER stress or inhibition of Jun amino-terminal kinases, which are activated as a consequence of ER stress, largely rescues cardiomyocytes from imatinib-induced death.  Thus, cardiotoxicity is an unanticipated side effect of inhibition of c-Abl by imatinib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGHOTag-dpJhjv2lLSLOxFfW6udTcc2ebqcaTXzMb--bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rhtlKrtg%253D%253D&md5=4012ddd42a942f1441abb54df1894db8</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnm1446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1446%26sid%3Dliteratum%253Aachs%26aulast%3DKerkela%26aufirst%3DR.%26aulast%3DGrazette%26aufirst%3DL.%26aulast%3DYacobi%26aufirst%3DR.%26aulast%3DIliescu%26aufirst%3DC.%26aulast%3DPatten%26aufirst%3DR.%26aulast%3DBeahm%26aufirst%3DC.%26aulast%3DWalters%26aufirst%3DB.%26aulast%3DShevtsov%26aufirst%3DS.%26aulast%3DPesant%26aufirst%3DS.%26aulast%3DClubb%26aufirst%3DF.%2BJ.%26aulast%3DRosenzweig%26aufirst%3DA.%26aulast%3DSalomon%26aufirst%3DR.%2BN.%26aulast%3DVan%2BEtten%26aufirst%3DR.%2BA.%26aulast%3DAlroy%26aufirst%3DJ.%26aulast%3DDurand%26aufirst%3DJ.-B.%26aulast%3DForce%26aufirst%3DT.%26atitle%3DCardiotoxicity%2520of%2520the%2520cancer%2520therapeutic%2520agent%2520imatinib%2520mesylate%26jtitle%3DNat.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D908%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: The development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+The+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lhekzeeR9WKaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520The%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+desirable+central+nervous+system+drug+space+through+the+alignment+of+molecular+properties%2C+in+vitro+ADME%2C+and+safety+attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0lhekzeeR9WKaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520desirable%2520central%2520nervous%2520system%2520drug%2520space%2520through%2520the%2520alignment%2520of%2520molecular%2520properties%252C%2520in%2520vitro%2520ADME%252C%2520and%2520safety%2520attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">Can we rationally design promiscuous drugs?</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1016%2Fj.sbi.2006.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=16442279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=127-136&author=A.+L.+Hopkinsauthor=J.+S.+Masonauthor=J.+P.+Overington&title=Can+we+rationally+design+promiscuous+drugs%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Can we rationally design promiscuous drugs?</span></div><div class="casAuthors">Hopkins, Andrew L.; Mason, Jonathan S.; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Structure-based drug design is now used widely in modern medicinal chem.  The application of structural biol. to medicinal chem. has heralded the 'rational drug design' vision of discovering exquisitely selective ligands.  However, recent advances in post-genomic biol. are indicating that polypharmacol. may be a necessary trait for the efficacy of many drugs, therefore questioning the 'one drug, one target' assumption of current rational drug design.  By combining advances in chemoinformatics and structural biol., it might be possible to rationally design the next generation of promiscuous drugs with polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWdh60x9AHrVg90H21EOLACvtfcHk0lhekzeeR9WKaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D&md5=8f9e95a41976b8e3ac790f2fff2c406f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2006.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2006.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DCan%2520we%2520rationally%2520design%2520promiscuous%2520drugs%253F%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2006%26volume%3D16%26spage%3D127%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Frantz, S.</span><span> </span><span class="NLM_article-title">Drug discovery: Playing dirty</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">437</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">–</span> <span class="NLM_lpage">943</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=2005&pages=942-943&author=S.+Frantz&title=Drug+discovery%3A+Playing+dirty"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrantz%26aufirst%3DS.%26atitle%3DDrug%2520discovery%253A%2520Playing%2520dirty%26jtitle%3DNature%26date%3D2005%26volume%3D437%26spage%3D942%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span> </span><span class="NLM_article-title">Turning promiscuous kinase inhibitors into safer drugs</span> <span class="citation_source-journal">Trends Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=295-301&author=X.+Zhangauthor=A.+Crespoauthor=A.+Fern%C3%A1ndez&title=Turning+promiscuous+kinase+inhibitors+into+safer+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26atitle%3DTurning%2520promiscuous%2520kinase%2520inhibitors%2520into%2520safer%2520drugs%26jtitle%3DTrends%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D295%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Long, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span> </span><span class="NLM_article-title">Structural basis for the interaction between casein kinase 1 delta and a potent and selective inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">956</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201387s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=956-960&author=A.+Longauthor=H.+Zhaoauthor=X.+Huang&title=Structural+basis+for+the+interaction+between+casein+kinase+1+delta+and+a+potent+and+selective+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm201387s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201387s%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DStructural%2520basis%2520for%2520the%2520interaction%2520between%2520casein%2520kinase%25201%2520delta%2520and%2520a%2520potent%2520and%2520selective%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D956%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Long, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span> </span><span class="NLM_article-title">Structural basis for the potent and selective inhibition of casein kinase 1 epsilon</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10307</span><span class="NLM_x">–</span> <span class="NLM_lpage">10311</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301336n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10307-10311&author=A.+Longauthor=H.+Zhaoauthor=X.+Huang&title=Structural+basis+for+the+potent+and+selective+inhibition+of+casein+kinase+1+epsilon"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm301336n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301336n%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DStructural%2520basis%2520for%2520the%2520potent%2520and%2520selective%2520inhibition%2520of%2520casein%2520kinase%25201%2520epsilon%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10307%26epage%3D10311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Perry, J. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moiani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tainer, J. A.</span><span> </span><span class="NLM_article-title">p38α MAP kinase C-terminal domain binding pocket characterized by crystallographic and computational analyses</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">391</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=2009&pages=1-11&author=J.+J.+P.+Perryauthor=R.+M.+Harrisauthor=D.+Moianiauthor=A.+J.+Olsonauthor=J.+A.+Tainer&title=p38%CE%B1+MAP+kinase+C-terminal+domain+binding+pocket+characterized+by+crystallographic+and+computational+analyses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DJ.%2BJ.%2BP.%26aulast%3DHarris%26aufirst%3DR.%2BM.%26aulast%3DMoiani%26aufirst%3DD.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DTainer%26aufirst%3DJ.%2BA.%26atitle%3Dp38%25CE%25B1%2520MAP%2520kinase%2520C-terminal%2520domain%2520binding%2520pocket%2520characterized%2520by%2520crystallographic%2520and%2520computational%2520analyses%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D391%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Graneto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vazquez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, H.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlitz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stallings, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naraian, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koszyk, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stealey, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weier, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mnich, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monahan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R.</span><span> </span><span class="NLM_article-title">Synthesis, crystal structure, and activity of pyrazole-based inhibitors of p38 kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5712</span><span class="NLM_x">–</span> <span class="NLM_lpage">5719</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0611915" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5712-5719&author=M.+J.+Granetoauthor=R.+G.+Kurumbailauthor=M.+L.+Vazquezauthor=H.-S.+Shiehauthor=J.+L.+Pawlitzauthor=J.+M.+Williamsauthor=W.+C.+Stallingsauthor=L.+Gengauthor=A.+S.+Naraianauthor=F.+J.+Koszykauthor=M.+A.+Stealeyauthor=X.+D.+Xuauthor=R.+M.+Weierauthor=G.+J.+Hansonauthor=R.+J.+Moureyauthor=R.+P.+Comptonauthor=S.+J.+Mnichauthor=G.+D.+Andersonauthor=J.+B.+Monahanauthor=R.+Devraj&title=Synthesis%2C+crystal+structure%2C+and+activity+of+pyrazole-based+inhibitors+of+p38+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm0611915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611915%26sid%3Dliteratum%253Aachs%26aulast%3DGraneto%26aufirst%3DM.%2BJ.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DVazquez%26aufirst%3DM.%2BL.%26aulast%3DShieh%26aufirst%3DH.-S.%26aulast%3DPawlitz%26aufirst%3DJ.%2BL.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DStallings%26aufirst%3DW.%2BC.%26aulast%3DGeng%26aufirst%3DL.%26aulast%3DNaraian%26aufirst%3DA.%2BS.%26aulast%3DKoszyk%26aufirst%3DF.%2BJ.%26aulast%3DStealey%26aufirst%3DM.%2BA.%26aulast%3DXu%26aufirst%3DX.%2BD.%26aulast%3DWeier%26aufirst%3DR.%2BM.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26aulast%3DCompton%26aufirst%3DR.%2BP.%26aulast%3DMnich%26aufirst%3DS.%2BJ.%26aulast%3DAnderson%26aufirst%3DG.%2BD.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26aulast%3DDevraj%26aufirst%3DR.%26atitle%3DSynthesis%252C%2520crystal%2520structure%252C%2520and%2520activity%2520of%2520pyrazole-based%2520inhibitors%2520of%2520p38%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5712%26epage%3D5719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Fitzgerald, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pikounis, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Keefe, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span> </span><span class="NLM_article-title">Structural basis for p38[alpha] MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">764</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1038%2Fnsb949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1GktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=764-769&author=C.+E.+Fitzgeraldauthor=S.+B.+Patelauthor=J.+W.+Beckerauthor=P.+M.+Cameronauthor=D.+Zallerauthor=V.+B.+Pikounisauthor=S.+J.+O%E2%80%99Keefeauthor=G.+Scapin&title=Structural+basis+for+p38%5Balpha%5D+MAP+kinase+quinazolinone+and+pyridol-pyrimidine+inhibitor+specificity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity</span></div><div class="casAuthors">Fitzgerald, Catherine E.; Patel, Sangita B.; Becker, Joseph W.; Cameron, Patricia M.; Zaller, Dennis; Pikounis, Vasilis Bill; O'Keefe, Stephen J.; Scapin, Giovanna</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">764-769</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The quinazolinone and pyridol-pyrimidine classes of p38 MAP kinase inhibitors have a previously unseen degree of specificity for p38 over other MAP kinases.  Comparison of the crystal structures of p38 bound to four different compds. shows that binding of the more specific mols. is characterized by a peptide flip between Met109 and Gly110.  Gly110 is a residue specific to the α, β and γ isoforms of p38.  The δ isoform and the other MAP kinases have bulkier residues in this position.  These residues would likely make the peptide flip energetically unfavorable, thus explaining the selectivity of binding.  To test this hypothesis, we constructed G110A and G110D mutants of p38 and measured the potency of several compds. against them.  The results confirm that the selectivity of quinazolinones and pyridol-pyrimidines results from the presence of a glycine in position 110.  This unique mode of binding may be exploited in the design of new p38 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb5LnKf2_OqbVg90H21EOLACvtfcHk0lgDTC4fpeZCZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1GktrY%253D&md5=85e063241af29ee0461a42e6d90514ba</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnsb949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb949%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DC.%2BE.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DBecker%26aufirst%3DJ.%2BW.%26aulast%3DCameron%26aufirst%3DP.%2BM.%26aulast%3DZaller%26aufirst%3DD.%26aulast%3DPikounis%26aufirst%3DV.%2BB.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DS.%2BJ.%26aulast%3DScapin%26aufirst%3DG.%26atitle%3DStructural%2520basis%2520for%2520p38%255Balpha%255D%2520MAP%2520kinase%2520quinazolinone%2520and%2520pyridol-pyrimidine%2520inhibitor%2520specificity%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D10%26spage%3D764%26epage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Mente, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span> </span><span class="NLM_article-title">Getting the MAX out of computational models: The prediction of unbound-brain and unbound-plasma maximum concentrations</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300029a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=515-519&author=S.+Menteauthor=A.+Doranauthor=T.+T.+Wager&title=Getting+the+MAX+out+of+computational+models%3A+The+prediction+of+unbound-brain+and+unbound-plasma+maximum+concentrations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fml300029a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300029a%26sid%3Dliteratum%253Aachs%26aulast%3DMente%26aufirst%3DS.%26aulast%3DDoran%26aufirst%3DA.%26aulast%3DWager%26aufirst%3DT.%2BT.%26atitle%3DGetting%2520the%2520MAX%2520out%2520of%2520computational%2520models%253A%2520The%2520prediction%2520of%2520unbound-brain%2520and%2520unbound-plasma%2520maximum%2520concentrations%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D515%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Schmidtke, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span> </span><span class="NLM_article-title">Shielded hydrogen bonds as structural determinants of binding kinetics: Application in drug design</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">18903</span><span class="NLM_x">–</span> <span class="NLM_lpage">18910</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja207494u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Ort7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=18903-18910&author=P.+Schmidtkeauthor=F.+J.+Luqueauthor=J.+B.+Murrayauthor=X.+Barril&title=Shielded+hydrogen+bonds+as+structural+determinants+of+binding+kinetics%3A+Application+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Shielded Hydrogen Bonds as Structural Determinants of Binding Kinetics: Application in Drug Design</span></div><div class="casAuthors">Schmidtke, Peter; Luque, F. Javier; Murray, James B.; Barril, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">18903-18910</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Time scale control of mol. interactions is an essential part of biochem. systems, but very little is known about the structural factors governing the kinetics of mol. recognition.  In drug design, the lifetime of drug-target complexes is a major determinant of pharmacol. effects but the absence of structure-kinetic relationships precludes rational optimization of this property.  Almost buried polar atoms-a common feature on protein binding sites-tend to form hydrogen bonds that are shielded from water.  Formation and rupture of this type of hydrogen bonds involves an energetically penalized transition state because it occurs asynchronously with dehydration/rehydration.  In consequence, water-shielded hydrogen bonds are exchanged at slower rates.  Occurrence of this phenomenon can be anticipated from simple structural anal., affording a novel tool to interpret and predict structure-kinetics relationships.  The validity of this principle has been investigated on two pairs of Hsp90 inhibitors for which detailed thermodn. and kinetic data has been exptl. detd.  The agreement between macroscopic observables and mol. simulations confirms the role of water-shielded hydrogen bonds as kinetic traps and illustrates how the authors' finding could be used as an aid in structure-based drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozQcgRgDTxL7Vg90H21EOLACvtfcHk0liZjn_8X3TRYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Ort7zP&md5=f2a69f635c4a8083d4b7ade4c1f01030</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fja207494u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja207494u%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidtke%26aufirst%3DP.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMurray%26aufirst%3DJ.%2BB.%26aulast%3DBarril%26aufirst%3DX.%26atitle%3DShielded%2520hydrogen%2520bonds%2520as%2520structural%2520determinants%2520of%2520binding%2520kinetics%253A%2520Application%2520in%2520drug%2520design%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D18903%26epage%3D18910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span> </span><span class="NLM_article-title">Predicting drug–hERG channel interactions that cause acquired long QT syndrome</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=119-24&author=M.+C.+Sanguinettiauthor=J.+S.+Mitcheson&title=Predicting+drug%E2%80%93hERG+channel+interactions+that+cause+acquired+long+QT+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26atitle%3DPredicting%2520drug%25E2%2580%2593hERG%2520channel%2520interactions%2520that%2520cause%2520acquired%2520long%2520QT%2520syndrome%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D119%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poluzzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">Toward a pharmacophore for drugs inducing the long QT syndrome: Insights from a CoMFA study of HERG K+ channel blockers</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3844</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0208875" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFalsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3844-53&author=A.+Cavalliauthor=E.+Poluzziauthor=P.+F.+Deauthor=M.+Recanatini&title=Toward+a+pharmacophore+for+drugs+inducing+the+long+QT+syndrome%3A+Insights+from+a+CoMFA+study+of+HERG+K%2B+channel+blockers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K+ channel blockers</span></div><div class="casAuthors">Cavalli, Andrea; Poluzzi, Elisabetta; De Ponti, Fabrizio; Recanatini, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3844-3853</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper, we present a pharmacophore for QT-prolonging drugs, along with a 3D QSAR (CoMFA) study for a series of very structurally variegate HERG K+ channel blockers.  The blockade of HERG K+ channels is one of the most important mol. mechanisms through which QT-prolonging drugs increase cardiac action potential duration.  Since QT prolongation is one of the most undesirable side effects of drugs, we first tried to identify the min. set of mol. features responsible for this action and then we attempted to develop a quant. model correlating the 3D stereoelectronic characteristics of the mols. with their HERG blocking potency.  Having considered an initial set of 31 QT-prolonging drugs for which the HERG K+ channel blocking activity was measured on mammalian transfected cells, we started the construction of a theor. screening tool able to predict whether a new mol. can interact with the HERG channel and eventually induce the long QT syndrome.  This in silico tool might be useful in the design of new drug candidates devoid of the physicochem. features likely to cause the above-mentioned side effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7WFt3kf6ZVLVg90H21EOLACvtfcHk0liZjn_8X3TRYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFalsrk%253D&md5=5e980476ccc9a8a6244aaab230eeb701</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm0208875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0208875%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DPoluzzi%26aufirst%3DE.%26aulast%3DDe%26aufirst%3DP.%2BF.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3DToward%2520a%2520pharmacophore%2520for%2520drugs%2520inducing%2520the%2520long%2520QT%2520syndrome%253A%2520Insights%2520from%2520a%2520CoMFA%2520study%2520of%2520HERG%2520K%252B%2520channel%2520blockers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3844%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Aronov, A. M.</span><span> </span><span class="NLM_article-title">Ligand structural aspects of hERG channel blockade</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1113</span><span class="NLM_x">–</span> <span class="NLM_lpage">1127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.2174%2F156802608785700061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=18782007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1113-1127&author=A.+M.+Aronov&title=Ligand+structural+aspects+of+hERG+channel+blockade"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand structural aspects of hERG channel blockade</span></div><div class="casAuthors">Aronov, Alex M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1113-1127</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sudden death as a side effect of action of non-antiarrhythmic drugs is a major pharmacol. safety concern facing the pharmaceutical industry and the health regulatory authorities.  A no. of drugs have been withdrawn from the market in recent years due to cardiovascular toxicity assocd. with undesirable blockade of hERG potassium channel.  Pharmaceuticals of widely varying structure have been shown to interact with hERG.  Defining the mol. features that confer hERG inhibitory activity has therefore become a focus of considerable computational and statistical modeling efforts.  Some of the approaches are aimed primarily at filtering out potential hERG blockers in the context of virtual libraries, while others involve understanding structure-activity relationships governing hERG-drug interactions.  The ability of models to produce structural hypotheses that can be tested by the project teams has become the key prerequisite driving their organization-wide adoption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOveNNzD-TbLVg90H21EOLACvtfcHk0liZjn_8X3TRYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsrjE&md5=86bf7e5819d6ce234f850e17b7f397dd</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F156802608785700061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608785700061%26sid%3Dliteratum%253Aachs%26aulast%3DAronov%26aufirst%3DA.%2BM.%26atitle%3DLigand%2520structural%2520aspects%2520of%2520hERG%2520channel%2520blockade%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1113%26epage%3D1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Seierstad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrafiotis, D. K.</span><span> </span><span class="NLM_article-title">A QSAR model of hERG binding using a large, diverse, and internally consistent training set</span> <span class="citation_source-journal">Chem. Biol. Drug Design</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1111%2Fj.1747-0285.2006.00379.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=16629826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD28XltF2ms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=284-296&author=M.+Seierstadauthor=D.+K.+Agrafiotis&title=A+QSAR+model+of+hERG+binding+using+a+large%2C+diverse%2C+and+internally+consistent+training+set"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A QSAR model of hERG binding using a large, diverse, and internally consistent training set</span></div><div class="casAuthors">Seierstad, Mark; Agrafiotis, Dimitris K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">284-296</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Over the past decade, the pharmaceutical industry has begun to address an addn. to ADME/Tox profiling, i.e., the ability of a compd. to bind to and inhibit the human ether-a-go-go-related gene (hERG)-encoded cardiac potassium channel.  With the compilation of a large and diverse set of compds. measured in a single, consistent hERG channel inhibition assay, the authors recognized a unique opportunity to attempt to construct predictive QSAR models.  Early efforts with classification models built from this training set were very encouraging.  A systematic evaluation of regression models based on neural network ensembles is presented in conjunction with a variety of structure representations and feature selection algorithms.  The combination of these modeling techniques (neural networks to capture nonlinear relationships in the data, feature selection to prevent over-fitting, and aggregation to minimize model instability) produced models with very good internal cross-validation statistics and good predictivity on external data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKAkEcg1vnkrVg90H21EOLACvtfcHk0ljRJ892lAY5-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltF2ms70%253D&md5=33a4902103c8c8058edd06281abae93e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2006.00379.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2006.00379.x%26sid%3Dliteratum%253Aachs%26aulast%3DSeierstad%26aufirst%3DM.%26aulast%3DAgrafiotis%26aufirst%3DD.%2BK.%26atitle%3DA%2520QSAR%2520model%2520of%2520hERG%2520binding%2520using%2520a%2520large%252C%2520diverse%252C%2520and%2520internally%2520consistent%2520training%2520set%26jtitle%3DChem.%2520Biol.%2520Drug%2520Design%26date%3D2006%26volume%3D67%26spage%3D284%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Stary, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wacker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boukharta, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zachariae, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karimi-Nejad, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Åqvist, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vriend, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, B. L.</span><span> </span><span class="NLM_article-title">Toward a consensus model of the hERG potassium channel</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1002%2Fcmdc.200900461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=20104563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslensLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=455-467&author=A.+Staryauthor=S.+J.+Wackerauthor=L.+Boukhartaauthor=U.+Zachariaeauthor=Y.+Karimi-Nejadauthor=J.+%C3%85qvistauthor=G.+Vriendauthor=B.+L.+de+Groot&title=Toward+a+consensus+model+of+the+hERG+potassium+channel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Toward a consensus model of the hERG potassium channel</span></div><div class="casAuthors">Stary, Anna; Wacker, Soeren J.; Boukharta, Lars; Zachariae, Ulrich; Karimi-Nejad, Yasmin; Aqvist, Johan; Vriend, Gert; de Groot, Bert L.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">455-467</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Malfunction of hERG potassium channels, due to inherited mutations or inhibition by drugs, can cause long QT syndrome, which can lead to life-threatening arrhythmias.  A three-dimensional structure of hERG is a prerequisite to understand the mol. basis of hERG malfunction.  To achieve a consensus model, the authors carried out an extensive anal. of hERG models based on various alignments of helix S5.  They analyzed seven models using a combination of conventional geometry/packing/normality validation methods as well as mol. dynamics simulations and mol. docking.  A synthetic test set with the X-ray crystal structure of Kv1.2 with artificially shifted S5 sequences modeled into the structure served as a ref. case.  The authors docked the known hERG inhibitors (+)-cisapride, (S)-terfenadine, and MK-499 into the hERG models and simulation snapshots.  None of the single analyses unambiguously identified a preferred model, but the combination of all three revealed that there is only one model that fulfills all quality criteria.  This model is confirmed by a recent mutation scanning expt.  The authors expect the modeled structure to be useful as a basis both for computational studies of channel function and kinetics as well as the design of expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph_60Mkzv_XLVg90H21EOLACvtfcHk0ljRJ892lAY5-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslensLs%253D&md5=28460fbb960fc0453c01aac0c2b6d785</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900461%26sid%3Dliteratum%253Aachs%26aulast%3DStary%26aufirst%3DA.%26aulast%3DWacker%26aufirst%3DS.%2BJ.%26aulast%3DBoukharta%26aufirst%3DL.%26aulast%3DZachariae%26aufirst%3DU.%26aulast%3DKarimi-Nejad%26aufirst%3DY.%26aulast%3D%25C3%2585qvist%26aufirst%3DJ.%26aulast%3DVriend%26aufirst%3DG.%26aulast%3Dde%2BGroot%26aufirst%3DB.%2BL.%26atitle%3DToward%2520a%2520consensus%2520model%2520of%2520the%2520hERG%2520potassium%2520channel%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D455%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal emistry of hERG optimizations: Highlights and hang-ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+emistry+of+hERG+optimizations%3A+Highlights+and+hang-ups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520emistry%2520of%2520hERG%2520optimizations%253A%2520Highlights%2520and%2520hang-ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Gehlhaar, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkhivker, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rejto, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freer, S. T.</span><span> </span><span class="NLM_article-title">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally flexible docking by evolutionary programming</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1016%2F1074-5521%2895%2990050-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=9383433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=317-324&author=D.+K.+Gehlhaarauthor=G.+M.+Verkhivkerauthor=P.+A.+Rejtoauthor=C.+J.+Shermanauthor=D.+B.+Fogelauthor=L.+J.+Fogelauthor=S.+T.+Freer&title=Molecular+recognition+of+the+inhibitor+AG-1343+by+HIV-1+protease%3A+Conformationally+flexible+docking+by+evolutionary+programming"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally flexible docking by evolutionary programming</span></div><div class="casAuthors">Gehlhaar, Daniel K.; Verkhivker, Gennady M.; Rejto, Paul A.; Sherman, Christopher J.; Fogel, David B.; Fogel, Lawrence J.; Freer, Stephan T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">317-24</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">An important prerequisite for computational structure-based drug design is prediction of the structures of ligand-protein complexes that have not yet been exptl. detd. by x-ray crystallog. or NMR.  For this task, docking of rigid ligands is inadequate because it assumes knowledge of the conformation of the bound ligand.  Docking of flexible ligands would be desirable, but requires one to search an enormous conformational space.  We set out to develop a strategy for flexible docking by combining a simple model of ligand-protein interactions for mol. recognition with an evolutionary programming search technique.  We have developed an intermol. energy function that incorporates steric and hydrogen-bonding terms.  The parameters in this function were obtained by docking in three different protein systems.  The effectiveness of this method was demonstrated by conformationally flexible docking of the inhibitor AG-1343, a potential new drug against AIDS, into HIV-1 protease.  For this mol., which has nine rotatable bonds, the crystal structure was reproduced within 1.5 Å rootmean-square deviation 34 times in 100 simulations, each requiring eight minutes on a Silicon Graphics R4400 workstation.  The energy function correctly evaluates the crystal structure as the global energy min.  We believe that a soln. of the docking problem may be achieved by matching a simple model of mol. recognition with an efficient search procedure.  The necessary ingredients of a mol. recognition model include only steric and hydrogen-bond interaction terms.  Although these terms are not necessarily sufficient to predict binding affinity, they describe ligand-protein interactions faithfully enough to enable a docking program to predict the structure of the bound ligand.  This docking strategy thus provides an important tool for the interdisciplinary field of rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAErS8tcVx2bVg90H21EOLACvtfcHk0ljRJ892lAY5-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D&md5=527cfc114545ea76b64b48d0aee21856</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2F1074-5521%2895%2990050-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1074-5521%252895%252990050-0%26sid%3Dliteratum%253Aachs%26aulast%3DGehlhaar%26aufirst%3DD.%2BK.%26aulast%3DVerkhivker%26aufirst%3DG.%2BM.%26aulast%3DRejto%26aufirst%3DP.%2BA.%26aulast%3DSherman%26aufirst%3DC.%2BJ.%26aulast%3DFogel%26aufirst%3DD.%2BB.%26aulast%3DFogel%26aufirst%3DL.%2BJ.%26aulast%3DFreer%26aufirst%3DS.%2BT.%26atitle%3DMolecular%2520recognition%2520of%2520the%2520inhibitor%2520AG-1343%2520by%2520HIV-1%2520protease%253A%2520Conformationally%2520flexible%2520docking%2520by%2520evolutionary%2520programming%26jtitle%3DChem.%2520Biol.%26date%3D1995%26volume%3D2%26spage%3D317%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Anantanarayan, A.; Clare, M.; Collins, P. W.; Crich, J. Z.; Devraj, R.; Flynn, D. L.; Geng, L.; Graneto, M. J.; Hanau, C. E.; Hanson, G. J.; Hartman, S. J.; Hepperle, M.; Huang, H.; Koszyk, F. J.; Liao, S.; Metz, S.; Partis, R. A.; Perry, T. D.; Rao, S. N.; Selness, S. R.; South, M. S.; Stealey, M. A.; Talley, J. J.; Vazquez, M. L.; Weier, R. M.; Xu, X.; Khanna, I. K.; Yu, Y.</span> United States Patent 6,525,059 B1,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Anantanarayan%2C+A.%3B+Clare%2C+M.%3B+Collins%2C+P.+W.%3B+Crich%2C+J.+Z.%3B+Devraj%2C+R.%3B+Flynn%2C+D.+L.%3B+Geng%2C+L.%3B+Graneto%2C+M.+J.%3B+Hanau%2C+C.+E.%3B+Hanson%2C+G.+J.%3B+Hartman%2C+S.+J.%3B+Hepperle%2C+M.%3B+Huang%2C+H.%3B+Koszyk%2C+F.+J.%3B+Liao%2C+S.%3B+Metz%2C+S.%3B+Partis%2C+R.+A.%3B+Perry%2C+T.+D.%3B+Rao%2C+S.+N.%3B+Selness%2C+S.+R.%3B+South%2C+M.+S.%3B+Stealey%2C+M.+A.%3B+Talley%2C+J.+J.%3B+Vazquez%2C+M.+L.%3B+Weier%2C+R.+M.%3B+Xu%2C+X.%3B+Khanna%2C+I.+K.%3B+Yu%2C+Y.+United+States+Patent+6%2C525%2C059+B1%2C+2003."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAnantanarayan%26aufirst%3DA.%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="ref29_1"><span><span class="NLM_contrib-group">Flotow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiol, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roeske, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roach, P. J.</span><span> </span><span class="NLM_article-title">Phosphate groups as substrate determinants for casein kinase I action</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">14264</span><span class="NLM_x">–</span> <span class="NLM_lpage">14269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=14264-14269&author=H.+Flotowauthor=P.+R.+Gravesauthor=A.+Q.+Wangauthor=C.+J.+Fiolauthor=R.+W.+Roeskeauthor=P.+J.+Roach&title=Phosphate+groups+as+substrate+determinants+for+casein+kinase+I+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref29_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlotow%26aufirst%3DH.%26aulast%3DGraves%26aufirst%3DP.%2BR.%26aulast%3DWang%26aufirst%3DA.%2BQ.%26aulast%3DFiol%26aufirst%3DC.%2BJ.%26aulast%3DRoeske%26aufirst%3DR.%2BW.%26aulast%3DRoach%26aufirst%3DP.%2BJ.%26atitle%3DPhosphate%2520groups%2520as%2520substrate%2520determinants%2520for%2520casein%2520kinase%2520I%2520action%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26spage%3D14264%26epage%3D14269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="ref30_1"><span><span class="NLM_contrib-group">Banker, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. A.</span><span> </span><span class="NLM_article-title">Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/ref30_1&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1002%2Fjps.10332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/ref30_1&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=12712416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/ref30_1&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1ehsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=967-974&author=M.+J.+Bankerauthor=T.+H.+Clarkauthor=J.+A.+Williams&title=Development+and+validation+of+a+96-well+equilibrium+dialysis+apparatus+for+measuring+plasma+protein+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref30_1R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding</span></div><div class="casAuthors">Banker, Michael J.; Clark, Tracey H.; Williams, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">967-974</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A 96-well equil. dialysis block was designed and constructed that is compatible with most std. 96-well format lab. supplies and instruments.  The unique design of the dialysis app. allows one to dispense and aspirate from either or both the sample and dialyzate sides from the top of the app., which is not possible with systems currently on the market.  This feature permits the investigator to analyze a large no. of samples, time points, or replicates in the same expt.  The novel alignment of the dialysis membrane vertically in the well maximizes the surface-to-vol. ratio, eliminates problems assocd. with trapped air pockets, and allows one to add or remove samples independently or all at once.  Furthermore, the design of the app. allows both the sample and dialyzate sides of the dialysis well to be accessible by robotic systems, so assays can be readily automated.  Teflon construction is used to minimize nonspecific binding of test samples to the app.  The device is reusable, easily assembled, and can be shaken in controlled temp. environments to decrease the time required to reach equil. as well as facilitate dissoln. of test compds.  Plasma protein binding values obtained for 10 diverse compds. using std. dialysis equipment and the 96-well dialysis block validates this method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp9qyX_9tHHrVg90H21EOLACvtfcHk0liGATtfsfa3oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1ehsrs%253D&md5=0948f0a11373c57be06be9e0d604ad40</span></div><a href="/servlet/linkout?suffix=ref30_1&amp;dbid=16384&amp;doi=10.1002%2Fjps.10332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10332%26sid%3Dliteratum%253Aachs%26aulast%3DBanker%26aufirst%3DM.%2BJ.%26aulast%3DClark%26aufirst%3DT.%2BH.%26aulast%3DWilliams%26aufirst%3DJ.%2BA.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%252096-well%2520equilibrium%2520dialysis%2520apparatus%2520for%2520measuring%2520plasma%2520protein%2520binding%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D967%26epage%3D974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['ref29_1'],'ref30':['ref30_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 16 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Eleonora Cescon, Giovanni Bolcato, Stephanie Federico, Maicol Bissaro, Alice Valentini, Maria Grazia Ferlin, Gianpiero Spalluto, Mattia Sturlese, <span class="NLM_string-name hlFld-ContribAuthor">Stefano Moro</span>. </span><span class="cited-content_cbyCitation_article-title">Scaffold Repurposing of in-House Chemical Library toward the Identification of New Casein Kinase 1 δ Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (6)
                                     , 1168-1174. <a href="https://doi.org/10.1021/acsmedchemlett.0c00028" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00028%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DScaffold%252BRepurposing%252Bof%252Bin-House%252BChemical%252BLibrary%252Btoward%252Bthe%252BIdentification%252Bof%252BNew%252BCasein%252BKinase%252B1%252B%2525CE%2525B4%252BInhibitors%26aulast%3DCescon%26aufirst%3DEleonora%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19012020%26date%3D28042020%26date%3D04052020%26date%3D28042020%26volume%3D11%26issue%3D6%26spage%3D1168%26epage%3D1174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Knauber</span>, <span class="hlFld-ContribAuthor ">Ramalakshmi  Chandrasekaran</span>, <span class="hlFld-ContribAuthor ">Joseph W.  Tucker</span>, <span class="hlFld-ContribAuthor ">Jinshan Michael  Chen</span>, <span class="hlFld-ContribAuthor ">Matthew  Reese</span>, <span class="hlFld-ContribAuthor ">Danica A.  Rankic</span>, <span class="hlFld-ContribAuthor ">Neal  Sach</span>, and <span class="hlFld-ContribAuthor ">Christopher  Helal</span>  . </span><span class="cited-content_cbyCitation_article-title">Ru/Ni Dual Catalytic Desulfinative Photoredox Csp2–Csp3 Cross-Coupling of Alkyl Sulfinate Salts and Aryl Halides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (24)
                                     , 6566-6569. <a href="https://doi.org/10.1021/acs.orglett.7b03280" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b03280</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b03280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b03280%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRu%25252FNi%252BDual%252BCatalytic%252BDesulfinative%252BPhotoredox%252BCsp2%2525E2%252580%252593Csp3%252BCross-Coupling%252Bof%252BAlkyl%252BSulfinate%252BSalts%252Band%252BAryl%252BHalides%26aulast%3DKnauber%26aufirst%3DThomas%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D20102017%26date%3D28112017%26date%3D15122017%26volume%3D19%26issue%3D24%26spage%3D6566%26epage%3D6569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Travis T.  Wager</span>, <span class="hlFld-ContribAuthor ">Paul  Galatsis</span>, <span class="hlFld-ContribAuthor ">Ramalakshmi Y.  Chandrasekaran</span>, <span class="hlFld-ContribAuthor ">Todd W.  Butler</span>, <span class="hlFld-ContribAuthor ">Jianke  Li</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Scot  Mente</span>, <span class="hlFld-ContribAuthor ">Chakrapani  Subramanyam</span>, <span class="hlFld-ContribAuthor ">Shenping  Liu</span>, <span class="hlFld-ContribAuthor ">Angela C.  Doran</span>, <span class="hlFld-ContribAuthor ">Cheng  Chang</span>, <span class="hlFld-ContribAuthor ">Katherine  Fisher</span>, <span class="hlFld-ContribAuthor ">Sarah  Grimwood</span>, <span class="hlFld-ContribAuthor ">Joseph R.  Hedde</span>, <span class="hlFld-ContribAuthor ">Michael  Marconi</span>, and <span class="hlFld-ContribAuthor ">Klaas  Schildknegt</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (9)
                                     , 1995-2004. <a href="https://doi.org/10.1021/acschemneuro.7b00155" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00155</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00155%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DIdentification%252Band%252BProfiling%252Bof%252Ba%252BSelective%252Band%252BBrain%252BPenetrant%252BRadioligand%252Bfor%252Bin%252BVivo%252BTarget%252BOccupancy%252BMeasurement%252Bof%252BCasein%252BKinase%252B1%252B%252528CK1%252529%252BInhibitors%26aulast%3DWager%26aufirst%3DTravis%2BT.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D27042017%26date%3D13062017%26date%3D30062017%26date%3D20092017%26date%3D13062017%26volume%3D8%26issue%3D9%26spage%3D1995%26epage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Travis T.  Wager</span>, <span class="hlFld-ContribAuthor ">Ramalakshmi Y.  Chandrasekaran</span>, <span class="hlFld-ContribAuthor ">Jenifer  Bradley</span>, <span class="hlFld-ContribAuthor ">David  Rubitski</span>, <span class="hlFld-ContribAuthor ">Helen  Berke</span>, <span class="hlFld-ContribAuthor ">Scot  Mente</span>, <span class="hlFld-ContribAuthor ">Todd  Butler</span>, <span class="hlFld-ContribAuthor ">Angela  Doran</span>, <span class="hlFld-ContribAuthor ">Cheng  Chang</span>, <span class="hlFld-ContribAuthor ">Katherine  Fisher</span>, <span class="hlFld-ContribAuthor ">John  Knafels</span>, <span class="hlFld-ContribAuthor ">Shenping  Liu</span>, <span class="hlFld-ContribAuthor ">Jeff  Ohren</span>, <span class="hlFld-ContribAuthor ">Michael  Marconi</span>, <span class="hlFld-ContribAuthor ">George  DeMarco</span>, <span class="hlFld-ContribAuthor ">Blossom  Sneed</span>, <span class="hlFld-ContribAuthor ">Kevin  Walton</span>, <span class="hlFld-ContribAuthor ">David  Horton</span>, <span class="hlFld-ContribAuthor ">Amy  Rosado</span>, and <span class="hlFld-ContribAuthor ">Andy  Mead</span>  . </span><span class="cited-content_cbyCitation_article-title">Casein Kinase 1δ/ε Inhibitor PF-5006739 Attenuates Opioid Drug-Seeking Behavior. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2014,</strong> <em>5 </em>
                                    (12)
                                     , 1253-1265. <a href="https://doi.org/10.1021/cn500201x" title="DOI URL">https://doi.org/10.1021/cn500201x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn500201x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn500201x%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DCasein%252BKinase%252B1%2525CE%2525B4%25252F%2525CE%2525B5%252BInhibitor%252BPF-5006739%252BAttenuates%252BOpioid%252BDrug-Seeking%252BBehavior%26aulast%3DWager%26aufirst%3DTravis%2BT.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D02092014%26date%3D08102014%26date%3D28102014%26date%3D17122014%26date%3D09102014%26volume%3D5%26issue%3D12%26spage%3D1253%26epage%3D1265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chenxi  Du</span>, <span class="hlFld-ContribAuthor ">Hongyu  Yang</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Achieving effective and selective CK1 inhibitors through structure modification. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (5)
                                     , 505-528. <a href="https://doi.org/10.4155/fmc-2020-0215" title="DOI URL">https://doi.org/10.4155/fmc-2020-0215</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0215%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DAchieving%2525C2%2525A0effective%252Band%252Bselective%252BCK1%252Binhibitors%252Bthrough%252Bstructure%252Bmodification%26aulast%3DDu%26aufirst%3DChenxi%26date%3D2021%26volume%3D13%26issue%3D5%26spage%3D505%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hwangseo  Park</span>, <span class="hlFld-ContribAuthor ">Hoi-Yun  Jung</span>, <span class="hlFld-ContribAuthor ">Shinmee  Mah</span>, <span class="hlFld-ContribAuthor ">Kewon  Kim</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase and GPCR polypharmacological approach for the identification of efficient anticancer medicines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (41)
                                     , 8402-8413. <a href="https://doi.org/10.1039/D0OB01917H" title="DOI URL">https://doi.org/10.1039/D0OB01917H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB01917H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB01917H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DKinase%252Band%252BGPCR%252Bpolypharmacological%252Bapproach%252Bfor%252Bthe%252Bidentification%252Bof%252Befficient%252Banticancer%252Bmedicines%26aulast%3DPark%26aufirst%3DHwangseo%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D41%26spage%3D8402%26epage%3D8413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caroline L.  Benn</span>, <span class="hlFld-ContribAuthor ">Lee A.  Dawson</span>. </span><span class="cited-content_cbyCitation_article-title">Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Aging Neuroscience</span><span> <strong>2020,</strong> <em>12 </em><a href="https://doi.org/10.3389/fnagi.2020.00242" title="DOI URL">https://doi.org/10.3389/fnagi.2020.00242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnagi.2020.00242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnagi.2020.00242%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Aging%2520Neuroscience%26atitle%3DClinically%252BPrecedented%252BProtein%252BKinases%25253A%252BRationale%252Bfor%252BTheir%252BUse%252Bin%252BNeurodegenerative%252BDisease%26aulast%3DBenn%26aufirst%3DCaroline%2BL.%26date%3D2020%26date%3D2020%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maicol  Bissaro</span>, <span class="hlFld-ContribAuthor ">Stephanie  Federico</span>, <span class="hlFld-ContribAuthor ">Veronica  Salmaso</span>, <span class="hlFld-ContribAuthor ">Mattia  Sturlese</span>, <span class="hlFld-ContribAuthor ">Giampiero  Spalluto</span>, <span class="hlFld-ContribAuthor ">Stefano  Moro</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Protein Kinase CK1δ with Riluzole: Could It Be One of the Possible Missing Bricks to Interpret Its Effect in the Treatment of ALS from a Molecular Point of View?. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (24)
                                     , 2601-2605. <a href="https://doi.org/10.1002/cmdc.201800632" title="DOI URL">https://doi.org/10.1002/cmdc.201800632</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800632%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTargeting%252BProtein%252BKinase%252BCK1%2525CE%2525B4%252Bwith%252BRiluzole%25253A%252BCould%252BIt%252BBe%252BOne%252Bof%252Bthe%252BPossible%252BMissing%252BBricks%252Bto%252BInterpret%252BIts%252BEffect%252Bin%252Bthe%252BTreatment%252Bof%252BALS%252Bfrom%252Ba%252BMolecular%252BPoint%252Bof%252BView%25253F%26aulast%3DBissaro%26aufirst%3DMaicol%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D24%26spage%3D2601%26epage%3D2605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Llorach-Pares</span>, <span class="hlFld-ContribAuthor ">Alfons  Nonell-Canals</span>, <span class="hlFld-ContribAuthor ">Conxita  Avila</span>, <span class="hlFld-ContribAuthor ">Melchor  Sanchez-Martinez</span>. </span><span class="cited-content_cbyCitation_article-title">Kororamides, Convolutamines, and Indole Derivatives as Possible Tau and Dual-Specificity Kinase Inhibitors for Alzheimer’s Disease: A Computational Study. </span><span class="cited-content_cbyCitation_journal-name">Marine Drugs</span><span> <strong>2018,</strong> <em>16 </em>
                                    (10)
                                     , 386. <a href="https://doi.org/10.3390/md16100386" title="DOI URL">https://doi.org/10.3390/md16100386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/md16100386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmd16100386%26sid%3Dliteratum%253Aachs%26jtitle%3DMarine%2520Drugs%26atitle%3DKororamides%25252C%252BConvolutamines%25252C%252Band%252BIndole%252BDerivatives%252Bas%252BPossible%252BTau%252Band%252BDual-Specificity%252BKinase%252BInhibitors%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BA%252BComputational%252BStudy%26aulast%3DLlorach-Pares%26aufirst%3DLaura%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D10%26spage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Llorach-Pares</span>, <span class="hlFld-ContribAuthor ">Alfons  Nonell-Canals</span>, <span class="hlFld-ContribAuthor ">Melchor  Sanchez-Martinez</span>, <span class="hlFld-ContribAuthor ">Conxita  Avila</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-Aided Drug Design Applied to Marine Drug Discovery: Meridianins as Alzheimer’s Disease Therapeutic Agents. </span><span class="cited-content_cbyCitation_journal-name">Marine Drugs</span><span> <strong>2017,</strong> <em>15 </em>
                                    (12)
                                     , 366. <a href="https://doi.org/10.3390/md15120366" title="DOI URL">https://doi.org/10.3390/md15120366</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/md15120366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmd15120366%26sid%3Dliteratum%253Aachs%26jtitle%3DMarine%2520Drugs%26atitle%3DComputer-Aided%252BDrug%252BDesign%252BApplied%252Bto%252BMarine%252BDrug%252BDiscovery%25253A%252BMeridianins%252Bas%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BTherapeutic%252BAgents%26aulast%3DLlorach-Pares%26aufirst%3DLaura%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D12%26spage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jakob  Halekotte</span>, <span class="hlFld-ContribAuthor ">Lydia  Witt</span>, <span class="hlFld-ContribAuthor ">Chiara  Ianes</span>, <span class="hlFld-ContribAuthor ">Marc  Krüger</span>, <span class="hlFld-ContribAuthor ">Mike  Bührmann</span>, <span class="hlFld-ContribAuthor ">Daniel  Rauh</span>, <span class="hlFld-ContribAuthor ">Christian  Pichlo</span>, <span class="hlFld-ContribAuthor ">Elena  Brunstein</span>, <span class="hlFld-ContribAuthor ">Andreas  Luxenburger</span>, <span class="hlFld-ContribAuthor ">Ulrich  Baumann</span>, <span class="hlFld-ContribAuthor ">Uwe  Knippschild</span>, <span class="hlFld-ContribAuthor ">Joachim  Bischof</span>, <span class="hlFld-ContribAuthor ">Christian  Peifer</span>. </span><span class="cited-content_cbyCitation_article-title">Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (4)
                                     , 522. <a href="https://doi.org/10.3390/molecules22040522" title="DOI URL">https://doi.org/10.3390/molecules22040522</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22040522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22040522%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DOptimized%252B4%25252C5-Diarylimidazoles%252Bas%252BPotent%25252FSelective%252BInhibitors%252Bof%252BProtein%252BKinase%252BCK1%2525CE%2525B4%252Band%252BTheir%252BStructural%252BRelation%252Bto%252Bp38%2525CE%2525B1%252BMAPK%26aulast%3DHalekotte%26aufirst%3DJakob%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D4%26spage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael U.  Luescher</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Bode</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Synthesis of N-Unprotected Piperazines, Morpholines, and Thiomorpholines from Aldehydes and SnAP Reagents. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2015,</strong> <em>127 </em>
                                    (37)
                                     , 11034-11038. <a href="https://doi.org/10.1002/ange.201505167" title="DOI URL">https://doi.org/10.1002/ange.201505167</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201505167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201505167%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DCatalytic%252BSynthesis%252Bof%252BN-Unprotected%252BPiperazines%25252C%252BMorpholines%25252C%252Band%252BThiomorpholines%252Bfrom%252BAldehydes%252Band%252BSnAP%252BReagents%26aulast%3DLuescher%26aufirst%3DMichael%2BU.%26date%3D2015%26date%3D2015%26volume%3D127%26issue%3D37%26spage%3D11034%26epage%3D11038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael U.  Luescher</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Bode</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Synthesis of N-Unprotected Piperazines, Morpholines, and Thiomorpholines from Aldehydes and SnAP Reagents. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2015,</strong> <em>54 </em>
                                    (37)
                                     , 10884-10888. <a href="https://doi.org/10.1002/anie.201505167" title="DOI URL">https://doi.org/10.1002/anie.201505167</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201505167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201505167%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DCatalytic%252BSynthesis%252Bof%252BN-Unprotected%252BPiperazines%25252C%252BMorpholines%25252C%252Band%252BThiomorpholines%252Bfrom%252BAldehydes%252Band%252BSnAP%252BReagents%26aulast%3DLuescher%26aufirst%3DMichael%2BU.%26date%3D2015%26date%3D2015%26volume%3D54%26issue%3D37%26spage%3D10884%26epage%3D10888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Genovino</span>, <span class="hlFld-ContribAuthor ">Dalibor  Sames</span>, <span class="hlFld-ContribAuthor ">B. Barry  Touré</span>. </span><span class="cited-content_cbyCitation_article-title">Access to drug metabolites via C–H functionalization: copper-catalyzed aerobic oxidation of  N , N -dimethylalkylamines in complex pharmaceuticals. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (23)
                                     , 3066-3069. <a href="https://doi.org/10.1016/j.tetlet.2014.11.037" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.11.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.11.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.11.037%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAccess%252Bto%252Bdrug%252Bmetabolites%252Bvia%252BC%2525E2%252580%252593H%252Bfunctionalization%25253A%252Bcopper-catalyzed%252Baerobic%252Boxidation%252Bof%252BN%252B%25252C%252BN%252B-dimethylalkylamines%252Bin%252Bcomplex%252Bpharmaceuticals%26aulast%3DGenovino%26aufirst%3DJulien%26date%3D2015%26volume%3D56%26issue%3D23%26spage%3D3066%26epage%3D3069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John H.  Ryan</span>, <span class="hlFld-ContribAuthor ">Jason A.  Smith</span>, <span class="hlFld-ContribAuthor ">Christopher  Hyland</span>, <span class="hlFld-ContribAuthor ">Adam G.  Meyer</span>, <span class="hlFld-ContribAuthor ">Charlotte C.  Williams</span>, <span class="hlFld-ContribAuthor ">Alex C.  Bissember</span>, <span class="hlFld-ContribAuthor ">Jeremy  Just</span>. </span><span class="cited-content_cbyCitation_article-title">Seven-Membered Rings. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 521-571. <a href="https://doi.org/10.1016/B978-0-08-100017-5.00016-9" title="DOI URL">https://doi.org/10.1016/B978-0-08-100017-5.00016-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-100017-5.00016-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-100017-5.00016-9%26sid%3Dliteratum%253Aachs%26atitle%3DSeven-Membered%252BRings%26aulast%3DRyan%26aufirst%3DJohn%2BH.%26date%3D2014%26spage%3D521%26epage%3D571%26pub%3DElsevier%26date%3D2014%26volume%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/medium/jm-2013-006324_0011.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4006324&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/medium/jm-2013-006324_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4006324&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/medium/jm-2013-006324_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 2-Substituted Pyridyl Analogs <b>2</b>–<b>4</b></div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4006324&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 2 equiv of LHMDS, THF, 0 °C to rt, 3.75 h (crude); (ii) 1.1 equiv of DMF-DMA, reflux, 72 h (crude); (iii) 1.2 equiv of methylhydrazine, EtOH, 0 °C, 3 h (31% over three steps); (iv) 1.2 equiv of <i>m</i>CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt, 18 h (99%); (v) 1.3 equiv of TMS-CN, 1.2 equiv of dimethylcarbamoyl chloride, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h (86%); (vi) H<sub>2</sub> (50 psi), catalytic sponge Ni, 7 N ammonia in MeOH, THF, rt, 2 h (99%); (vii) ethyl formate, 70 °C, 3 h (80%); (viii) 1.5 equiv of MeI, 1.2 equiv of NaH, THF, rt, 18 h (90%); (ix) MeOH/12 N HCl (10:1 v/v), reflux, 90 min, followed by isopropyl alcohol/MeOH recryst 56%); (x) 1.25 M HCl/MeOH, reflux 20 h, (55%); (xi) 1 M LAH/THF, rt, 30 min (25%).</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/medium/jm-2013-006324_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Fused Oxazepine <b>5</b></div><p class="last"><sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4006324&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 2 equiv of <i>n</i>-BuLi, THF, −70 °C then 1.5 equiv of <b>20</b>, 1.5 h (44%); (ii) 0.9 equiv of <b>21</b>, 2 mol % of Pd(OAc)<sub>2</sub>, 4 mol % of Xphos, 1.2 equiv of Cs<sub>2</sub>CO<sub>3</sub>, ACN/H<sub>2</sub>O (5:1), reflux, 3 h (80%); (iii) 1.4 equiv of <b>24</b>, 1.7 equiv of NaH, THF, −20 to −5 °C, 4 h, (70%); (iv) concd H<sub>2</sub>SO<sub>4</sub>, 110 °C, 10 min; (v) 5 N NaOH, pH 7.0 phosphate buffer, 110 °C, 3 h, 80% from <b>25</b>; (vi) 2.25 equiv of LAH/THF, 50 °C, 2 h; (vii) 2 equiv of <i>p</i>-toluenesulfonic acid, MeOH, 42% from <b>26</b>.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/medium/jm-2013-006324_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Morpholine <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4006324&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 5 mol % of Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, 2 equiv of CsF, DMF, 140 °C, 2 h (80%); (ii) 1 equiv of <i>n</i>-BuLi, toluene, 1 equiv of <b>30</b>, −78 °C, 1.5 h (22%) (iii) 10 equiv of 1.0 M HCl/EtOH, EtOH, rt, 12 h (assumed 100%); (iv) 4 equiv of NaBH<sub>4</sub>, MeOH, −40 °C to rt, 30 min (26%).</p></p></figure><figure data-id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/medium/jm-2013-006324_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Binding of inhibitors to p38a (red box; compound <b>2</b>) and CK1δ (ribbon diagram and green boxes; compounds <b>3</b>–<b>6</b>). All structures share a common interaction of the pyridine core interacting as a single point binder with the hinge (Met109/Leu85) of p38/CK1δ. Also conserved in all structures is the pyrazole nitrogen interacting through a water molecule with the catalytic Lys38, as well as the <i>p</i>-fluoro aryl ring occupying the hydrophobic selectivity pocket of p38. Selective CK1δ inhibitors (<b>3</b>–<b>6</b>) make additional hinge interaction with the proline carbonyl of CK1δ. Compounds <b>3</b>–<b>6</b> also hydrogen bond to the carbonyl oxygens of both residues Leu85 and Gly86.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4006324&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/medium/jm-2013-006324_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. View of backbone carbonyls of CK1δ (white wire with compound <b>3</b>) and p38 (green wire). Comparing the angle between the carbonyl groups (C═O vector) gives values of 41 for Leu85 (Met109 in p38), 117 for the Gly86 (Gly110 in p38), and 80 for Pro87 (Ala111 in p38).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4006324&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/medium/jm-2013-006324_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Mouse circadian rhythm shift (<i>y</i>-axis, in hours) versus compound (<i>x</i>-axis). Top and lower bounds of boxes refer to 75th and 25th percentile values. Mean shifts are −1.5, −2.9, and −1.2 h (<i>p</i> < 0.001 for all three) for compounds <b>4</b>, <b>5</b>, and <b>6</b> respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-17/jm4006324/production/images/large/jm-2013-006324_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4006324&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43200" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43200" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Price, M. A.</span><span> </span><span class="NLM_article-title">CKI, there’s more than one: Casein kinase I family members in Wnt and hedgehog signaling</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=399-410&author=M.+A.+Price&title=CKI%2C+there%E2%80%99s+more+than+one%3A+Casein+kinase+I+family+members+in+Wnt+and+hedgehog+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DM.%2BA.%26atitle%3DCKI%252C%2520there%25E2%2580%2599s%2520more%2520than%2520one%253A%2520Casein%2520kinase%2520I%2520family%2520members%2520in%2520Wnt%2520and%2520hedgehog%2520signaling%26jtitle%3DGenes%2520Dev.%26date%3D2006%26volume%3D20%26spage%3D399%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Gallego, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virshup, D. M.</span><span> </span><span class="NLM_article-title">Post-translational modifications regulate the ticking of the circadian clock</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1038%2Fnrm2106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=17245414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFKlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=139-148&author=M.+Gallegoauthor=D.+M.+Virshup&title=Post-translational+modifications+regulate+the+ticking+of+the+circadian+clock"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Post-translational modifications regulate the ticking of the circadian clock</span></div><div class="casAuthors">Gallego, Monica; Virshup, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-148</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Getting a good night's sleep is on everyone's to-do list.  So is, no doubt, staying awake during late afternoon seminars.  Our internal clocks control these and many more workings of the body, and disruptions of the circadian clocks predispose individuals to depression, obesity and cancer.  Mutations in kinases and phosphatases in hamsters, flies, fungi and humans highlight how our timepieces are regulated and provide clues as to how we might be able to manipulate them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriwqkvC7R2HbVg90H21EOLACvtfcHk0liHxQKe64Jb4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFKlsg%253D%253D&md5=60be65c47ffadcc453b2f7257adbc511</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrm2106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2106%26sid%3Dliteratum%253Aachs%26aulast%3DGallego%26aufirst%3DM.%26aulast%3DVirshup%26aufirst%3DD.%2BM.%26atitle%3DPost-translational%2520modifications%2520regulate%2520the%2520ticking%2520of%2520the%2520circadian%2520clock%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D139%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Knippschild, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gocht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löhler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stöter, M.</span><span> </span><span class="NLM_article-title">The casein kinase 1 family: Participation in multiple cellular processes in eukaryotes</span> <span class="citation_source-journal">Cell. Signal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">689</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1016%2Fj.cellsig.2004.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=15722192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslWltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=675-689&author=U.+Knippschildauthor=A.+Gochtauthor=S.+Wolffauthor=N.+Huberauthor=J.+L%C3%B6hlerauthor=M.+St%C3%B6ter&title=The+casein+kinase+1+family%3A+Participation+in+multiple+cellular+processes+in+eukaryotes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The casein kinase 1 family: participation in multiple cellular processes in eukaryotes</span></div><div class="casAuthors">Knippschild, Uwe; Gocht, Andreas; Wolff, Sonja; Huber, Nadine; Loehler, Juergen; Stoeter, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">675-689</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Phosphorylation of Ser, Thr, and Tyr residues by cellular protein kinases plays an important role in the regulation of various cellular processes.  The Ser/Thr-specific casein kinase 1 and 2 protein kinase families, CK1 and CK2, resp., were among the 1st protein kinases that had been described.  In recent years, knowledge of the regulation and function of mammalian CK1 kinase family members has rapidly increased.  Extracellular stimuli, the subcellular localization of CK1 isoforms, their interaction with various cellular structures and proteins, as well as autophosphorylation and proteolytic cleavage of their C-terminal regulatory domains influence CK1 kinase activity.  Mammalian CK1 isoforms phosphorylate many different substrates, among them key regulatory proteins involved in the control of cell differentiation, proliferation, chromosome segregation, and circadian rhythms.  De-regulation and/or the incidence of mutations in the coding sequence of CK1 isoforms have been linked to neurodegenerative diseases and cancer.  Here, the authors summarize the current knowledge about the function and regulation of mammalian CK1 isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYTGvFy5TMyLVg90H21EOLACvtfcHk0liHxQKe64Jb4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslWltb4%253D&md5=e44cbddc335887723b171bf889dd2f08</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2004.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2004.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnippschild%26aufirst%3DU.%26aulast%3DGocht%26aufirst%3DA.%26aulast%3DWolff%26aufirst%3DS.%26aulast%3DHuber%26aufirst%3DN.%26aulast%3DL%25C3%25B6hler%26aufirst%3DJ.%26aulast%3DSt%25C3%25B6ter%26aufirst%3DM.%26atitle%3DThe%2520casein%2520kinase%25201%2520family%253A%2520Participation%2520in%2520multiple%2520cellular%2520processes%2520in%2520eukaryotes%26jtitle%3DCell.%2520Signal.%26date%3D2005%26volume%3D17%26spage%3D675%26epage%3D689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Galatsis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offord, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMarco, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohren, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mente, S.</span><span> </span><span class="NLM_article-title">Chapter 3—Central modulation of circadian rhythm via CK1 inhibition for psychiatric indications</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=33-51&author=P.+Galatsisauthor=T.+T.+Wagerauthor=J.+Offordauthor=G.+J.+DeMarcoauthor=J.+F.+Ohrenauthor=I.+Efremovauthor=S.+Mente&title=Chapter+3%E2%80%94Central+modulation+of+circadian+rhythm+via+CK1+inhibition+for+psychiatric+indications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalatsis%26aufirst%3DP.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DOfford%26aufirst%3DJ.%26aulast%3DDeMarco%26aufirst%3DG.%2BJ.%26aulast%3DOhren%26aufirst%3DJ.%2BF.%26aulast%3DEfremov%26aufirst%3DI.%26aulast%3DMente%26aufirst%3DS.%26atitle%3DChapter%25203%25E2%2580%2594Central%2520modulation%2520of%2520circadian%2520rhythm%2520via%2520CK1%2520inhibition%2520for%2520psychiatric%2520indications%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D33%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Badura, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adamowicz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianfrogna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Germain, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprouse, J.</span><span> </span><span class="NLM_article-title">An inhibitor of casein kinase Iε induces phase delays in circadian rhythms under free-running and entrained conditions</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1124%2Fjpet.107.122846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=17502429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslSjuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2007&pages=730-738&author=L.+Baduraauthor=T.+Swansonauthor=W.+Adamowiczauthor=J.+Adamsauthor=J.+Cianfrognaauthor=K.+Fisherauthor=J.+Hollandauthor=R.+Kleimanauthor=F.+Nelsonauthor=L.+Reynoldsauthor=K.+St.+Germainauthor=E.+Schaefferauthor=B.+Tateauthor=J.+Sprouse&title=An+inhibitor+of+casein+kinase+I%CE%B5+induces+phase+delays+in+circadian+rhythms+under+free-running+and+entrained+conditions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">An inhibitor of casein kinase Iε induces phase delays in circadian rhythms under free-running and entrained conditions</span></div><div class="casAuthors">Badura, Lori; Swanson, Terri; Adamowicz, Wendy; Adams, Jessica; Cianfrogna, Julie; Fisher, Katherine; Holland, Janice; Kleiman, Robin; Nelson, Frederick; Reynolds, Linda; St. Germain, Kristin; Schaeffer, Eric; Tate, Barbara; Sprouse, Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">730-738</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Casein kinase Iε (CKIε) is an essential component of the biol. clock, phosphorylating PER proteins, and in doing so regulating their turnover and nuclear entry in oscillator cells of the suprachiasmatic nucleus (SCN).  Although hereditary decreases in PER phosphorylation have been well characterized, little is known about the consequences of acute enzyme inhibition by pharmacol. means.  A novel reagent, 4-[3-cyclohexyl-5-(4-fluoro-phenyl)-3H-imidazol-4-yl]-pyrimidin-2-ylamine (PF-670462), proved to be both a potent (IC50 = 7.7 ± 2.2 nM) and selective (>30-fold with respect to 42 addnl. kinases) inhibitor of CKIε in isolated enzyme prepns.; in transfected whole cell assays, it caused a concn.-related redistribution of nuclear vs. cytosolic PER.  When tested in free-running animals, 50 mg/kg s.c. PF-670462 produced robust phase delays when dosed at circadian time (CT)9 (-1.97 ± 0.17 h).  Entrained rats dosed in normal light-dark (LD) and then released to const. darkness also experienced phase delays that were dose- and time of dosing-dependent.  PF-670462 yielded only phase delays across the circadian cycle with the most sensitive time at CT12 when PER levels are near their peak in the SCN.  Most importantly, these drug-induced phase delays persisted in animals entrained and maintained in LD throughout the entire expt.; re-entrainment to the prevailing LD required days in contrast to the rapid elimination of the drug (t1/2 = 0.46 ± 0.04 h).  Together, these results suggest that inhibition of CKIε yields a perturbation of oscillator function that forestalls light as a zeitgeber, and they demonstrate that pharmacol. tools such as PF-670462 may yield valuable insight into clock function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfqMEeisE8I7Vg90H21EOLACvtfcHk0liHk5sHxKvuTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslSjuro%253D&md5=ec355b6d0cee0f1ad9d37cad55f0936d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.122846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.122846%26sid%3Dliteratum%253Aachs%26aulast%3DBadura%26aufirst%3DL.%26aulast%3DSwanson%26aufirst%3DT.%26aulast%3DAdamowicz%26aufirst%3DW.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DK.%26aulast%3DHolland%26aufirst%3DJ.%26aulast%3DKleiman%26aufirst%3DR.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DReynolds%26aufirst%3DL.%26aulast%3DSt.%2BGermain%26aufirst%3DK.%26aulast%3DSchaeffer%26aufirst%3DE.%26aulast%3DTate%26aufirst%3DB.%26aulast%3DSprouse%26aufirst%3DJ.%26atitle%3DAn%2520inhibitor%2520of%2520casein%2520kinase%2520I%25CE%25B5%2520induces%2520phase%2520delays%2520in%2520circadian%2520rhythms%2520under%2520free-running%2520and%2520entrained%2520conditions%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D322%26spage%3D730%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Walton, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubitski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, Q.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sladek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamohan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serpa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claffey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastings, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loudon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maywood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span> </span><span class="NLM_article-title">Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock period</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1124%2Fjpet.109.151415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=19458106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFClsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2009&pages=430-439&author=K.+M.+Waltonauthor=K.+Fisherauthor=D.+Rubitskiauthor=M.+Marconiauthor=Q.-J.+Mengauthor=M.+Sladekauthor=J.+Adamsauthor=M.+Bassauthor=R.+Chandrasekaranauthor=T.+Butlerauthor=M.+Grifforauthor=F.+Rajamohanauthor=M.+Serpaauthor=Y.+Chenauthor=M.+Claffeyauthor=M.+Hastingsauthor=A.+Loudonauthor=E.+Maywoodauthor=J.+Ohrenauthor=A.+Doranauthor=T.+T.+Wager&title=Selective+inhibition+of+casein+kinase+1+epsilon+minimally+alters+circadian+clock+period"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of casein kinase 1ε minimally alters circadian clock period</span></div><div class="casAuthors">Walton, Kevin M.; Fisher, Katherine; Rubitski, David; Marconi, Michael; Meng, Qing-Jun; Sladek, Martin; Adams, Jessica; Bass, Michael; Chandrasekaran, Rama; Butler, Todd; Griffor, Matt; Rajamohan, Francis; Serpa, Megan; Chen, Yuhpyng; Claffey, Michelle; Hastings, Michael; Loudon, Andrew; Maywood, Elizabeth; Ohren, Jeffrey; Doran, Angela; Wager, Travis T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">430-439</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The circadian clock links our daily cycles of sleep and activity to the external environment.  Deregulation of the clock is implicated in a no. of human disorders, including depression, seasonal affective disorder, and metabolic disorders.  Casein kinase 1 epsilon (CK1ε) and casein kinase 1 delta (CK1δ) are closely related Ser-Thr protein kinases that serve as key clock regulators as demonstrated by mammalian mutations in each that dramatically alter the circadian period.  Therefore, inhibitors of CK1δ/ε may have utility in treating circadian disorders.  Although we previously demonstrated that a pan-CK1δ/ε inhibitor, 4-[3-cyclohexyl-5-(4-fluoro-phenyl)-3H-imidazol-4-yl]-pyrimidin-2-ylamine (PF-670462), causes a significant phase delay in animal models of circadian rhythm, it remains unclear whether one of the kinases has a predominant role in regulating the circadian clock.  To test this, we have characterized 3-(3-chloro-phenoxymethyl)-1-(tetrahydro-pyran-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine (PF-4800567), a novel and potent inhibitor of CK1ε (IC50 = 32 nM) with greater than 20-fold selectivity over CK1δ.  PF-4800567 completely blocks CK1ε-mediated PER3 nuclear localization and PER2 degrdn.  In cycling Rat1 fibroblasts and a mouse model of circadian rhythm, however, PF-4800567 has only a minimal effect on the circadian clock at concns. substantially over its CK1ε IC50.  This is in contrast to the pan-CK1δ/ε inhibitor PF-670462 that robustly alters the circadian clock under similar conditions.  These data indicate that CK1ε is not the predominant mediator of circadian timing relative to CK1δ.  PF-4800567 should prove useful in probing unique roles between these two kinases in multiple signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbn1TWKcCGxrVg90H21EOLACvtfcHk0liHk5sHxKvuTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFClsL4%253D&md5=2efd448788149e6f563c226bc871f5c3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.151415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.151415%26sid%3Dliteratum%253Aachs%26aulast%3DWalton%26aufirst%3DK.%2BM.%26aulast%3DFisher%26aufirst%3DK.%26aulast%3DRubitski%26aufirst%3DD.%26aulast%3DMarconi%26aufirst%3DM.%26aulast%3DMeng%26aufirst%3DQ.-J.%26aulast%3DSladek%26aufirst%3DM.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DBass%26aufirst%3DM.%26aulast%3DChandrasekaran%26aufirst%3DR.%26aulast%3DButler%26aufirst%3DT.%26aulast%3DGriffor%26aufirst%3DM.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DSerpa%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DClaffey%26aufirst%3DM.%26aulast%3DHastings%26aufirst%3DM.%26aulast%3DLoudon%26aufirst%3DA.%26aulast%3DMaywood%26aufirst%3DE.%26aulast%3DOhren%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%26aulast%3DWager%26aufirst%3DT.%2BT.%26atitle%3DSelective%2520inhibition%2520of%2520casein%2520kinase%25201%2520epsilon%2520minimally%2520alters%2520circadian%2520clock%2520period%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D330%26spage%3D430%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Force, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaja, K. L.</span><span> </span><span class="NLM_article-title">Cardiotoxicity of kinase inhibitors: The prediction and translation of preclinical models to clinical outcomes</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1038%2Fnrd3252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=21283106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlektrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=111-126&author=T.+Forceauthor=K.+L.+Kolaja&title=Cardiotoxicity+of+kinase+inhibitors%3A+The+prediction+and+translation+of+preclinical+models+to+clinical+outcomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes</span></div><div class="casAuthors">Force, Thomas; Kolaja, Kyle L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-126</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Targeted therapeutics, particularly those that inhibit the activity of protein kinases that are mutated and/or overexpressed in cancer, have revolutionized the treatment of some cancers and improved survival rates in many others.  Although these agents dominate drug development in cancer, significant toxicities, including cardiotoxicity, have emerged.  In this Review, we examine the underlying mechanisms that result in on-target or off-target cardiotoxicities of small mol. kinase inhibitors.  We also discuss how well the various preclin. safety models and strategies might predict clin. cardiotoxicity.  It is hoped that a thorough understanding of the mechanisms underlying cardiotoxicity will lead to the development of safe, effective drugs and consequently, fewer costly surprises as agents progress through clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNZMyMbzgEU7Vg90H21EOLACvtfcHk0ljYjKKwCJiRQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlektrg%253D&md5=3528aab655aaac600639929dd8942f63</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd3252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3252%26sid%3Dliteratum%253Aachs%26aulast%3DForce%26aufirst%3DT.%26aulast%3DKolaja%26aufirst%3DK.%2BL.%26atitle%3DCardiotoxicity%2520of%2520kinase%2520inhibitors%253A%2520The%2520prediction%2520and%2520translation%2520of%2520preclinical%2520models%2520to%2520clinical%2520outcomes%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D111%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kerkela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grazette, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yacobi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iliescu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patten, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beahm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shevtsov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clubb, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Etten, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alroy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durand, J.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Force, T.</span><span> </span><span class="NLM_article-title">Cardiotoxicity of the cancer therapeutic agent imatinib mesylate</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1038%2Fnm1446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=16862153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A280%3ADC%252BD28rhtlKrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=908-916&author=R.+Kerkelaauthor=L.+Grazetteauthor=R.+Yacobiauthor=C.+Iliescuauthor=R.+Pattenauthor=C.+Beahmauthor=B.+Waltersauthor=S.+Shevtsovauthor=S.+Pesantauthor=F.+J.+Clubbauthor=A.+Rosenzweigauthor=R.+N.+Salomonauthor=R.+A.+Van+Ettenauthor=J.+Alroyauthor=J.-B.+Durandauthor=T.+Force&title=Cardiotoxicity+of+the+cancer+therapeutic+agent+imatinib+mesylate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiotoxicity of the cancer therapeutic agent imatinib mesylate</span></div><div class="casAuthors">Kerkela Risto; Grazette Luanda; Yacobi Rinat; Iliescu Cezar; Patten Richard; Beahm Cara; Walters Brian; Shevtsov Sergei; Pesant Stephanie; Clubb Fred J; Rosenzweig Anthony; Salomon Robert N; Van Etten Richard A; Alroy Joseph; Durand Jean-Bernard; Force Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">908-16</span>
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    </div><div class="casAbstract">Imatinib mesylate (Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia.  Here we report ten individuals who developed severe congestive heart failure while on imatinib and we show that imatinib-treated mice develop left ventricular contractile dysfunction.  Transmission electron micrographs from humans and mice treated with imatinib show mitochondrial abnormalities and accumulation of membrane whorls in both vacuoles and the sarco- (endo-) plasmic reticulum, findings suggestive of a toxic myopathy.  With imatinib treatment, cardiomyocytes in culture show activation of the endoplasmic reticulum (ER) stress response, collapse of the mitochondrial membrane potential, release of cytochrome c into the cytosol, reduction in cellular ATP content and cell death.  Retroviral gene transfer of an imatinib-resistant mutant of c-Abl, alleviation of ER stress or inhibition of Jun amino-terminal kinases, which are activated as a consequence of ER stress, largely rescues cardiomyocytes from imatinib-induced death.  Thus, cardiotoxicity is an unanticipated side effect of inhibition of c-Abl by imatinib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGHOTag-dpJhjv2lLSLOxFfW6udTcc2eYZfhX1iE-yaLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rhtlKrtg%253D%253D&md5=4012ddd42a942f1441abb54df1894db8</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnm1446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1446%26sid%3Dliteratum%253Aachs%26aulast%3DKerkela%26aufirst%3DR.%26aulast%3DGrazette%26aufirst%3DL.%26aulast%3DYacobi%26aufirst%3DR.%26aulast%3DIliescu%26aufirst%3DC.%26aulast%3DPatten%26aufirst%3DR.%26aulast%3DBeahm%26aufirst%3DC.%26aulast%3DWalters%26aufirst%3DB.%26aulast%3DShevtsov%26aufirst%3DS.%26aulast%3DPesant%26aufirst%3DS.%26aulast%3DClubb%26aufirst%3DF.%2BJ.%26aulast%3DRosenzweig%26aufirst%3DA.%26aulast%3DSalomon%26aufirst%3DR.%2BN.%26aulast%3DVan%2BEtten%26aufirst%3DR.%2BA.%26aulast%3DAlroy%26aufirst%3DJ.%26aulast%3DDurand%26aufirst%3DJ.-B.%26aulast%3DForce%26aufirst%3DT.%26atitle%3DCardiotoxicity%2520of%2520the%2520cancer%2520therapeutic%2520agent%2520imatinib%2520mesylate%26jtitle%3DNat.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D908%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: The development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+The+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0ljYjKKwCJiRQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520The%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+desirable+central+nervous+system+drug+space+through+the+alignment+of+molecular+properties%2C+in+vitro+ADME%2C+and+safety+attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0lgJtbYRgZIEDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520desirable%2520central%2520nervous%2520system%2520drug%2520space%2520through%2520the%2520alignment%2520of%2520molecular%2520properties%252C%2520in%2520vitro%2520ADME%252C%2520and%2520safety%2520attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">Can we rationally design promiscuous drugs?</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1016%2Fj.sbi.2006.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=16442279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=127-136&author=A.+L.+Hopkinsauthor=J.+S.+Masonauthor=J.+P.+Overington&title=Can+we+rationally+design+promiscuous+drugs%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Can we rationally design promiscuous drugs?</span></div><div class="casAuthors">Hopkins, Andrew L.; Mason, Jonathan S.; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Structure-based drug design is now used widely in modern medicinal chem.  The application of structural biol. to medicinal chem. has heralded the 'rational drug design' vision of discovering exquisitely selective ligands.  However, recent advances in post-genomic biol. are indicating that polypharmacol. may be a necessary trait for the efficacy of many drugs, therefore questioning the 'one drug, one target' assumption of current rational drug design.  By combining advances in chemoinformatics and structural biol., it might be possible to rationally design the next generation of promiscuous drugs with polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWdh60x9AHrVg90H21EOLACvtfcHk0lgJtbYRgZIEDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D&md5=8f9e95a41976b8e3ac790f2fff2c406f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2006.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2006.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DCan%2520we%2520rationally%2520design%2520promiscuous%2520drugs%253F%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2006%26volume%3D16%26spage%3D127%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Frantz, S.</span><span> </span><span class="NLM_article-title">Drug discovery: Playing dirty</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">437</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">–</span> <span class="NLM_lpage">943</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=2005&pages=942-943&author=S.+Frantz&title=Drug+discovery%3A+Playing+dirty"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrantz%26aufirst%3DS.%26atitle%3DDrug%2520discovery%253A%2520Playing%2520dirty%26jtitle%3DNature%26date%3D2005%26volume%3D437%26spage%3D942%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, A.</span><span> </span><span class="NLM_article-title">Turning promiscuous kinase inhibitors into safer drugs</span> <span class="citation_source-journal">Trends Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=295-301&author=X.+Zhangauthor=A.+Crespoauthor=A.+Fern%C3%A1ndez&title=Turning+promiscuous+kinase+inhibitors+into+safer+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DCrespo%26aufirst%3DA.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DA.%26atitle%3DTurning%2520promiscuous%2520kinase%2520inhibitors%2520into%2520safer%2520drugs%26jtitle%3DTrends%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D295%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Long, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span> </span><span class="NLM_article-title">Structural basis for the interaction between casein kinase 1 delta and a potent and selective inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">956</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201387s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=956-960&author=A.+Longauthor=H.+Zhaoauthor=X.+Huang&title=Structural+basis+for+the+interaction+between+casein+kinase+1+delta+and+a+potent+and+selective+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm201387s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201387s%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DStructural%2520basis%2520for%2520the%2520interaction%2520between%2520casein%2520kinase%25201%2520delta%2520and%2520a%2520potent%2520and%2520selective%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D956%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Long, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span> </span><span class="NLM_article-title">Structural basis for the potent and selective inhibition of casein kinase 1 epsilon</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10307</span><span class="NLM_x">–</span> <span class="NLM_lpage">10311</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301336n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10307-10311&author=A.+Longauthor=H.+Zhaoauthor=X.+Huang&title=Structural+basis+for+the+potent+and+selective+inhibition+of+casein+kinase+1+epsilon"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm301336n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301336n%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DStructural%2520basis%2520for%2520the%2520potent%2520and%2520selective%2520inhibition%2520of%2520casein%2520kinase%25201%2520epsilon%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10307%26epage%3D10311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Perry, J. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moiani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tainer, J. A.</span><span> </span><span class="NLM_article-title">p38α MAP kinase C-terminal domain binding pocket characterized by crystallographic and computational analyses</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">391</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=2009&pages=1-11&author=J.+J.+P.+Perryauthor=R.+M.+Harrisauthor=D.+Moianiauthor=A.+J.+Olsonauthor=J.+A.+Tainer&title=p38%CE%B1+MAP+kinase+C-terminal+domain+binding+pocket+characterized+by+crystallographic+and+computational+analyses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DJ.%2BJ.%2BP.%26aulast%3DHarris%26aufirst%3DR.%2BM.%26aulast%3DMoiani%26aufirst%3DD.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DTainer%26aufirst%3DJ.%2BA.%26atitle%3Dp38%25CE%25B1%2520MAP%2520kinase%2520C-terminal%2520domain%2520binding%2520pocket%2520characterized%2520by%2520crystallographic%2520and%2520computational%2520analyses%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D391%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Graneto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vazquez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, H.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlitz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stallings, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naraian, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koszyk, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stealey, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weier, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compton, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mnich, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monahan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R.</span><span> </span><span class="NLM_article-title">Synthesis, crystal structure, and activity of pyrazole-based inhibitors of p38 kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5712</span><span class="NLM_x">–</span> <span class="NLM_lpage">5719</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0611915" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5712-5719&author=M.+J.+Granetoauthor=R.+G.+Kurumbailauthor=M.+L.+Vazquezauthor=H.-S.+Shiehauthor=J.+L.+Pawlitzauthor=J.+M.+Williamsauthor=W.+C.+Stallingsauthor=L.+Gengauthor=A.+S.+Naraianauthor=F.+J.+Koszykauthor=M.+A.+Stealeyauthor=X.+D.+Xuauthor=R.+M.+Weierauthor=G.+J.+Hansonauthor=R.+J.+Moureyauthor=R.+P.+Comptonauthor=S.+J.+Mnichauthor=G.+D.+Andersonauthor=J.+B.+Monahanauthor=R.+Devraj&title=Synthesis%2C+crystal+structure%2C+and+activity+of+pyrazole-based+inhibitors+of+p38+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm0611915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611915%26sid%3Dliteratum%253Aachs%26aulast%3DGraneto%26aufirst%3DM.%2BJ.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DVazquez%26aufirst%3DM.%2BL.%26aulast%3DShieh%26aufirst%3DH.-S.%26aulast%3DPawlitz%26aufirst%3DJ.%2BL.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DStallings%26aufirst%3DW.%2BC.%26aulast%3DGeng%26aufirst%3DL.%26aulast%3DNaraian%26aufirst%3DA.%2BS.%26aulast%3DKoszyk%26aufirst%3DF.%2BJ.%26aulast%3DStealey%26aufirst%3DM.%2BA.%26aulast%3DXu%26aufirst%3DX.%2BD.%26aulast%3DWeier%26aufirst%3DR.%2BM.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26aulast%3DCompton%26aufirst%3DR.%2BP.%26aulast%3DMnich%26aufirst%3DS.%2BJ.%26aulast%3DAnderson%26aufirst%3DG.%2BD.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26aulast%3DDevraj%26aufirst%3DR.%26atitle%3DSynthesis%252C%2520crystal%2520structure%252C%2520and%2520activity%2520of%2520pyrazole-based%2520inhibitors%2520of%2520p38%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5712%26epage%3D5719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Fitzgerald, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pikounis, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Keefe, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span> </span><span class="NLM_article-title">Structural basis for p38[alpha] MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">764</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1038%2Fnsb949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1GktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=764-769&author=C.+E.+Fitzgeraldauthor=S.+B.+Patelauthor=J.+W.+Beckerauthor=P.+M.+Cameronauthor=D.+Zallerauthor=V.+B.+Pikounisauthor=S.+J.+O%E2%80%99Keefeauthor=G.+Scapin&title=Structural+basis+for+p38%5Balpha%5D+MAP+kinase+quinazolinone+and+pyridol-pyrimidine+inhibitor+specificity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity</span></div><div class="casAuthors">Fitzgerald, Catherine E.; Patel, Sangita B.; Becker, Joseph W.; Cameron, Patricia M.; Zaller, Dennis; Pikounis, Vasilis Bill; O'Keefe, Stephen J.; Scapin, Giovanna</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">764-769</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The quinazolinone and pyridol-pyrimidine classes of p38 MAP kinase inhibitors have a previously unseen degree of specificity for p38 over other MAP kinases.  Comparison of the crystal structures of p38 bound to four different compds. shows that binding of the more specific mols. is characterized by a peptide flip between Met109 and Gly110.  Gly110 is a residue specific to the α, β and γ isoforms of p38.  The δ isoform and the other MAP kinases have bulkier residues in this position.  These residues would likely make the peptide flip energetically unfavorable, thus explaining the selectivity of binding.  To test this hypothesis, we constructed G110A and G110D mutants of p38 and measured the potency of several compds. against them.  The results confirm that the selectivity of quinazolinones and pyridol-pyrimidines results from the presence of a glycine in position 110.  This unique mode of binding may be exploited in the design of new p38 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb5LnKf2_OqbVg90H21EOLACvtfcHk0lgMtLlHOYpggg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1GktrY%253D&md5=85e063241af29ee0461a42e6d90514ba</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnsb949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb949%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DC.%2BE.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DBecker%26aufirst%3DJ.%2BW.%26aulast%3DCameron%26aufirst%3DP.%2BM.%26aulast%3DZaller%26aufirst%3DD.%26aulast%3DPikounis%26aufirst%3DV.%2BB.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DS.%2BJ.%26aulast%3DScapin%26aufirst%3DG.%26atitle%3DStructural%2520basis%2520for%2520p38%255Balpha%255D%2520MAP%2520kinase%2520quinazolinone%2520and%2520pyridol-pyrimidine%2520inhibitor%2520specificity%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D10%26spage%3D764%26epage%3D769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Mente, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span> </span><span class="NLM_article-title">Getting the MAX out of computational models: The prediction of unbound-brain and unbound-plasma maximum concentrations</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300029a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=515-519&author=S.+Menteauthor=A.+Doranauthor=T.+T.+Wager&title=Getting+the+MAX+out+of+computational+models%3A+The+prediction+of+unbound-brain+and+unbound-plasma+maximum+concentrations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fml300029a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300029a%26sid%3Dliteratum%253Aachs%26aulast%3DMente%26aufirst%3DS.%26aulast%3DDoran%26aufirst%3DA.%26aulast%3DWager%26aufirst%3DT.%2BT.%26atitle%3DGetting%2520the%2520MAX%2520out%2520of%2520computational%2520models%253A%2520The%2520prediction%2520of%2520unbound-brain%2520and%2520unbound-plasma%2520maximum%2520concentrations%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D515%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Schmidtke, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span> </span><span class="NLM_article-title">Shielded hydrogen bonds as structural determinants of binding kinetics: Application in drug design</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">18903</span><span class="NLM_x">–</span> <span class="NLM_lpage">18910</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja207494u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Ort7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2011&pages=18903-18910&author=P.+Schmidtkeauthor=F.+J.+Luqueauthor=J.+B.+Murrayauthor=X.+Barril&title=Shielded+hydrogen+bonds+as+structural+determinants+of+binding+kinetics%3A+Application+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Shielded Hydrogen Bonds as Structural Determinants of Binding Kinetics: Application in Drug Design</span></div><div class="casAuthors">Schmidtke, Peter; Luque, F. Javier; Murray, James B.; Barril, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">18903-18910</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Time scale control of mol. interactions is an essential part of biochem. systems, but very little is known about the structural factors governing the kinetics of mol. recognition.  In drug design, the lifetime of drug-target complexes is a major determinant of pharmacol. effects but the absence of structure-kinetic relationships precludes rational optimization of this property.  Almost buried polar atoms-a common feature on protein binding sites-tend to form hydrogen bonds that are shielded from water.  Formation and rupture of this type of hydrogen bonds involves an energetically penalized transition state because it occurs asynchronously with dehydration/rehydration.  In consequence, water-shielded hydrogen bonds are exchanged at slower rates.  Occurrence of this phenomenon can be anticipated from simple structural anal., affording a novel tool to interpret and predict structure-kinetics relationships.  The validity of this principle has been investigated on two pairs of Hsp90 inhibitors for which detailed thermodn. and kinetic data has been exptl. detd.  The agreement between macroscopic observables and mol. simulations confirms the role of water-shielded hydrogen bonds as kinetic traps and illustrates how the authors' finding could be used as an aid in structure-based drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozQcgRgDTxL7Vg90H21EOLACvtfcHk0liokc10XYkUxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Ort7zP&md5=f2a69f635c4a8083d4b7ade4c1f01030</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fja207494u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja207494u%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidtke%26aufirst%3DP.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMurray%26aufirst%3DJ.%2BB.%26aulast%3DBarril%26aufirst%3DX.%26atitle%3DShielded%2520hydrogen%2520bonds%2520as%2520structural%2520determinants%2520of%2520binding%2520kinetics%253A%2520Application%2520in%2520drug%2520design%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2011%26volume%3D133%26spage%3D18903%26epage%3D18910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span> </span><span class="NLM_article-title">Predicting drug–hERG channel interactions that cause acquired long QT syndrome</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=119-24&author=M.+C.+Sanguinettiauthor=J.+S.+Mitcheson&title=Predicting+drug%E2%80%93hERG+channel+interactions+that+cause+acquired+long+QT+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26atitle%3DPredicting%2520drug%25E2%2580%2593hERG%2520channel%2520interactions%2520that%2520cause%2520acquired%2520long%2520QT%2520syndrome%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D119%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poluzzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">Toward a pharmacophore for drugs inducing the long QT syndrome: Insights from a CoMFA study of HERG K+ channel blockers</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3844</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0208875" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFalsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3844-53&author=A.+Cavalliauthor=E.+Poluzziauthor=P.+F.+Deauthor=M.+Recanatini&title=Toward+a+pharmacophore+for+drugs+inducing+the+long+QT+syndrome%3A+Insights+from+a+CoMFA+study+of+HERG+K%2B+channel+blockers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K+ channel blockers</span></div><div class="casAuthors">Cavalli, Andrea; Poluzzi, Elisabetta; De Ponti, Fabrizio; Recanatini, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3844-3853</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this paper, we present a pharmacophore for QT-prolonging drugs, along with a 3D QSAR (CoMFA) study for a series of very structurally variegate HERG K+ channel blockers.  The blockade of HERG K+ channels is one of the most important mol. mechanisms through which QT-prolonging drugs increase cardiac action potential duration.  Since QT prolongation is one of the most undesirable side effects of drugs, we first tried to identify the min. set of mol. features responsible for this action and then we attempted to develop a quant. model correlating the 3D stereoelectronic characteristics of the mols. with their HERG blocking potency.  Having considered an initial set of 31 QT-prolonging drugs for which the HERG K+ channel blocking activity was measured on mammalian transfected cells, we started the construction of a theor. screening tool able to predict whether a new mol. can interact with the HERG channel and eventually induce the long QT syndrome.  This in silico tool might be useful in the design of new drug candidates devoid of the physicochem. features likely to cause the above-mentioned side effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7WFt3kf6ZVLVg90H21EOLACvtfcHk0liokc10XYkUxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFalsrk%253D&md5=5e980476ccc9a8a6244aaab230eeb701</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm0208875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0208875%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DPoluzzi%26aufirst%3DE.%26aulast%3DDe%26aufirst%3DP.%2BF.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3DToward%2520a%2520pharmacophore%2520for%2520drugs%2520inducing%2520the%2520long%2520QT%2520syndrome%253A%2520Insights%2520from%2520a%2520CoMFA%2520study%2520of%2520HERG%2520K%252B%2520channel%2520blockers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3844%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Aronov, A. M.</span><span> </span><span class="NLM_article-title">Ligand structural aspects of hERG channel blockade</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1113</span><span class="NLM_x">–</span> <span class="NLM_lpage">1127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.2174%2F156802608785700061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=18782007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1113-1127&author=A.+M.+Aronov&title=Ligand+structural+aspects+of+hERG+channel+blockade"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand structural aspects of hERG channel blockade</span></div><div class="casAuthors">Aronov, Alex M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1113-1127</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sudden death as a side effect of action of non-antiarrhythmic drugs is a major pharmacol. safety concern facing the pharmaceutical industry and the health regulatory authorities.  A no. of drugs have been withdrawn from the market in recent years due to cardiovascular toxicity assocd. with undesirable blockade of hERG potassium channel.  Pharmaceuticals of widely varying structure have been shown to interact with hERG.  Defining the mol. features that confer hERG inhibitory activity has therefore become a focus of considerable computational and statistical modeling efforts.  Some of the approaches are aimed primarily at filtering out potential hERG blockers in the context of virtual libraries, while others involve understanding structure-activity relationships governing hERG-drug interactions.  The ability of models to produce structural hypotheses that can be tested by the project teams has become the key prerequisite driving their organization-wide adoption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOveNNzD-TbLVg90H21EOLACvtfcHk0liokc10XYkUxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKmsrjE&md5=86bf7e5819d6ce234f850e17b7f397dd</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F156802608785700061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608785700061%26sid%3Dliteratum%253Aachs%26aulast%3DAronov%26aufirst%3DA.%2BM.%26atitle%3DLigand%2520structural%2520aspects%2520of%2520hERG%2520channel%2520blockade%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1113%26epage%3D1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Seierstad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrafiotis, D. K.</span><span> </span><span class="NLM_article-title">A QSAR model of hERG binding using a large, diverse, and internally consistent training set</span> <span class="citation_source-journal">Chem. Biol. Drug Design</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1111%2Fj.1747-0285.2006.00379.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=16629826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD28XltF2ms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=284-296&author=M.+Seierstadauthor=D.+K.+Agrafiotis&title=A+QSAR+model+of+hERG+binding+using+a+large%2C+diverse%2C+and+internally+consistent+training+set"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A QSAR model of hERG binding using a large, diverse, and internally consistent training set</span></div><div class="casAuthors">Seierstad, Mark; Agrafiotis, Dimitris K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">284-296</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Over the past decade, the pharmaceutical industry has begun to address an addn. to ADME/Tox profiling, i.e., the ability of a compd. to bind to and inhibit the human ether-a-go-go-related gene (hERG)-encoded cardiac potassium channel.  With the compilation of a large and diverse set of compds. measured in a single, consistent hERG channel inhibition assay, the authors recognized a unique opportunity to attempt to construct predictive QSAR models.  Early efforts with classification models built from this training set were very encouraging.  A systematic evaluation of regression models based on neural network ensembles is presented in conjunction with a variety of structure representations and feature selection algorithms.  The combination of these modeling techniques (neural networks to capture nonlinear relationships in the data, feature selection to prevent over-fitting, and aggregation to minimize model instability) produced models with very good internal cross-validation statistics and good predictivity on external data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKAkEcg1vnkrVg90H21EOLACvtfcHk0lhFnGis3FE3-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltF2ms70%253D&md5=33a4902103c8c8058edd06281abae93e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2006.00379.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2006.00379.x%26sid%3Dliteratum%253Aachs%26aulast%3DSeierstad%26aufirst%3DM.%26aulast%3DAgrafiotis%26aufirst%3DD.%2BK.%26atitle%3DA%2520QSAR%2520model%2520of%2520hERG%2520binding%2520using%2520a%2520large%252C%2520diverse%252C%2520and%2520internally%2520consistent%2520training%2520set%26jtitle%3DChem.%2520Biol.%2520Drug%2520Design%26date%3D2006%26volume%3D67%26spage%3D284%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Stary, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wacker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boukharta, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zachariae, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karimi-Nejad, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Åqvist, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vriend, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, B. L.</span><span> </span><span class="NLM_article-title">Toward a consensus model of the hERG potassium channel</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1002%2Fcmdc.200900461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=20104563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslensLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=455-467&author=A.+Staryauthor=S.+J.+Wackerauthor=L.+Boukhartaauthor=U.+Zachariaeauthor=Y.+Karimi-Nejadauthor=J.+%C3%85qvistauthor=G.+Vriendauthor=B.+L.+de+Groot&title=Toward+a+consensus+model+of+the+hERG+potassium+channel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Toward a consensus model of the hERG potassium channel</span></div><div class="casAuthors">Stary, Anna; Wacker, Soeren J.; Boukharta, Lars; Zachariae, Ulrich; Karimi-Nejad, Yasmin; Aqvist, Johan; Vriend, Gert; de Groot, Bert L.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">455-467</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Malfunction of hERG potassium channels, due to inherited mutations or inhibition by drugs, can cause long QT syndrome, which can lead to life-threatening arrhythmias.  A three-dimensional structure of hERG is a prerequisite to understand the mol. basis of hERG malfunction.  To achieve a consensus model, the authors carried out an extensive anal. of hERG models based on various alignments of helix S5.  They analyzed seven models using a combination of conventional geometry/packing/normality validation methods as well as mol. dynamics simulations and mol. docking.  A synthetic test set with the X-ray crystal structure of Kv1.2 with artificially shifted S5 sequences modeled into the structure served as a ref. case.  The authors docked the known hERG inhibitors (+)-cisapride, (S)-terfenadine, and MK-499 into the hERG models and simulation snapshots.  None of the single analyses unambiguously identified a preferred model, but the combination of all three revealed that there is only one model that fulfills all quality criteria.  This model is confirmed by a recent mutation scanning expt.  The authors expect the modeled structure to be useful as a basis both for computational studies of channel function and kinetics as well as the design of expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph_60Mkzv_XLVg90H21EOLACvtfcHk0lhFnGis3FE3-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslensLs%253D&md5=28460fbb960fc0453c01aac0c2b6d785</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900461%26sid%3Dliteratum%253Aachs%26aulast%3DStary%26aufirst%3DA.%26aulast%3DWacker%26aufirst%3DS.%2BJ.%26aulast%3DBoukharta%26aufirst%3DL.%26aulast%3DZachariae%26aufirst%3DU.%26aulast%3DKarimi-Nejad%26aufirst%3DY.%26aulast%3D%25C3%2585qvist%26aufirst%3DJ.%26aulast%3DVriend%26aufirst%3DG.%26aulast%3Dde%2BGroot%26aufirst%3DB.%2BL.%26atitle%3DToward%2520a%2520consensus%2520model%2520of%2520the%2520hERG%2520potassium%2520channel%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D455%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal emistry of hERG optimizations: Highlights and hang-ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+emistry+of+hERG+optimizations%3A+Highlights+and+hang-ups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520emistry%2520of%2520hERG%2520optimizations%253A%2520Highlights%2520and%2520hang-ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Gehlhaar, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkhivker, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rejto, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freer, S. T.</span><span> </span><span class="NLM_article-title">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally flexible docking by evolutionary programming</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1016%2F1074-5521%2895%2990050-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=9383433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=317-324&author=D.+K.+Gehlhaarauthor=G.+M.+Verkhivkerauthor=P.+A.+Rejtoauthor=C.+J.+Shermanauthor=D.+B.+Fogelauthor=L.+J.+Fogelauthor=S.+T.+Freer&title=Molecular+recognition+of+the+inhibitor+AG-1343+by+HIV-1+protease%3A+Conformationally+flexible+docking+by+evolutionary+programming"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally flexible docking by evolutionary programming</span></div><div class="casAuthors">Gehlhaar, Daniel K.; Verkhivker, Gennady M.; Rejto, Paul A.; Sherman, Christopher J.; Fogel, David B.; Fogel, Lawrence J.; Freer, Stephan T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">317-24</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">An important prerequisite for computational structure-based drug design is prediction of the structures of ligand-protein complexes that have not yet been exptl. detd. by x-ray crystallog. or NMR.  For this task, docking of rigid ligands is inadequate because it assumes knowledge of the conformation of the bound ligand.  Docking of flexible ligands would be desirable, but requires one to search an enormous conformational space.  We set out to develop a strategy for flexible docking by combining a simple model of ligand-protein interactions for mol. recognition with an evolutionary programming search technique.  We have developed an intermol. energy function that incorporates steric and hydrogen-bonding terms.  The parameters in this function were obtained by docking in three different protein systems.  The effectiveness of this method was demonstrated by conformationally flexible docking of the inhibitor AG-1343, a potential new drug against AIDS, into HIV-1 protease.  For this mol., which has nine rotatable bonds, the crystal structure was reproduced within 1.5 Å rootmean-square deviation 34 times in 100 simulations, each requiring eight minutes on a Silicon Graphics R4400 workstation.  The energy function correctly evaluates the crystal structure as the global energy min.  We believe that a soln. of the docking problem may be achieved by matching a simple model of mol. recognition with an efficient search procedure.  The necessary ingredients of a mol. recognition model include only steric and hydrogen-bond interaction terms.  Although these terms are not necessarily sufficient to predict binding affinity, they describe ligand-protein interactions faithfully enough to enable a docking program to predict the structure of the bound ligand.  This docking strategy thus provides an important tool for the interdisciplinary field of rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAErS8tcVx2bVg90H21EOLACvtfcHk0lh-bP4Vd5gLpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D&md5=527cfc114545ea76b64b48d0aee21856</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2F1074-5521%2895%2990050-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1074-5521%252895%252990050-0%26sid%3Dliteratum%253Aachs%26aulast%3DGehlhaar%26aufirst%3DD.%2BK.%26aulast%3DVerkhivker%26aufirst%3DG.%2BM.%26aulast%3DRejto%26aufirst%3DP.%2BA.%26aulast%3DSherman%26aufirst%3DC.%2BJ.%26aulast%3DFogel%26aufirst%3DD.%2BB.%26aulast%3DFogel%26aufirst%3DL.%2BJ.%26aulast%3DFreer%26aufirst%3DS.%2BT.%26atitle%3DMolecular%2520recognition%2520of%2520the%2520inhibitor%2520AG-1343%2520by%2520HIV-1%2520protease%253A%2520Conformationally%2520flexible%2520docking%2520by%2520evolutionary%2520programming%26jtitle%3DChem.%2520Biol.%26date%3D1995%26volume%3D2%26spage%3D317%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Anantanarayan, A.; Clare, M.; Collins, P. W.; Crich, J. Z.; Devraj, R.; Flynn, D. L.; Geng, L.; Graneto, M. J.; Hanau, C. E.; Hanson, G. J.; Hartman, S. J.; Hepperle, M.; Huang, H.; Koszyk, F. J.; Liao, S.; Metz, S.; Partis, R. A.; Perry, T. D.; Rao, S. N.; Selness, S. R.; South, M. S.; Stealey, M. A.; Talley, J. J.; Vazquez, M. L.; Weier, R. M.; Xu, X.; Khanna, I. K.; Yu, Y.</span> United States Patent 6,525,059 B1,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Anantanarayan%2C+A.%3B+Clare%2C+M.%3B+Collins%2C+P.+W.%3B+Crich%2C+J.+Z.%3B+Devraj%2C+R.%3B+Flynn%2C+D.+L.%3B+Geng%2C+L.%3B+Graneto%2C+M.+J.%3B+Hanau%2C+C.+E.%3B+Hanson%2C+G.+J.%3B+Hartman%2C+S.+J.%3B+Hepperle%2C+M.%3B+Huang%2C+H.%3B+Koszyk%2C+F.+J.%3B+Liao%2C+S.%3B+Metz%2C+S.%3B+Partis%2C+R.+A.%3B+Perry%2C+T.+D.%3B+Rao%2C+S.+N.%3B+Selness%2C+S.+R.%3B+South%2C+M.+S.%3B+Stealey%2C+M.+A.%3B+Talley%2C+J.+J.%3B+Vazquez%2C+M.+L.%3B+Weier%2C+R.+M.%3B+Xu%2C+X.%3B+Khanna%2C+I.+K.%3B+Yu%2C+Y.+United+States+Patent+6%2C525%2C059+B1%2C+2003."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAnantanarayan%26aufirst%3DA.%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-ref29_1"><span><span class="NLM_contrib-group">Flotow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiol, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roeske, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roach, P. J.</span><span> </span><span class="NLM_article-title">Phosphate groups as substrate determinants for casein kinase I action</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">14264</span><span class="NLM_x">–</span> <span class="NLM_lpage">14269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=14264-14269&author=H.+Flotowauthor=P.+R.+Gravesauthor=A.+Q.+Wangauthor=C.+J.+Fiolauthor=R.+W.+Roeskeauthor=P.+J.+Roach&title=Phosphate+groups+as+substrate+determinants+for+casein+kinase+I+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref29_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlotow%26aufirst%3DH.%26aulast%3DGraves%26aufirst%3DP.%2BR.%26aulast%3DWang%26aufirst%3DA.%2BQ.%26aulast%3DFiol%26aufirst%3DC.%2BJ.%26aulast%3DRoeske%26aufirst%3DR.%2BW.%26aulast%3DRoach%26aufirst%3DP.%2BJ.%26atitle%3DPhosphate%2520groups%2520as%2520substrate%2520determinants%2520for%2520casein%2520kinase%2520I%2520action%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26spage%3D14264%26epage%3D14269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-ref30_1"><span><span class="NLM_contrib-group">Banker, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. A.</span><span> </span><span class="NLM_article-title">Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/ref30_1&amp;dbid=16&amp;doi=10.1021%2Fjm4006324&amp;key=10.1002%2Fjps.10332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/ref30_1&amp;dbid=8&amp;doi=10.1021%2Fjm4006324&amp;key=12712416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/ref30_1&amp;dbid=32&amp;doi=10.1021%2Fjm4006324&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1ehsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=967-974&author=M.+J.+Bankerauthor=T.+H.+Clarkauthor=J.+A.+Williams&title=Development+and+validation+of+a+96-well+equilibrium+dialysis+apparatus+for+measuring+plasma+protein+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref30_1R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding</span></div><div class="casAuthors">Banker, Michael J.; Clark, Tracey H.; Williams, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">967-974</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A 96-well equil. dialysis block was designed and constructed that is compatible with most std. 96-well format lab. supplies and instruments.  The unique design of the dialysis app. allows one to dispense and aspirate from either or both the sample and dialyzate sides from the top of the app., which is not possible with systems currently on the market.  This feature permits the investigator to analyze a large no. of samples, time points, or replicates in the same expt.  The novel alignment of the dialysis membrane vertically in the well maximizes the surface-to-vol. ratio, eliminates problems assocd. with trapped air pockets, and allows one to add or remove samples independently or all at once.  Furthermore, the design of the app. allows both the sample and dialyzate sides of the dialysis well to be accessible by robotic systems, so assays can be readily automated.  Teflon construction is used to minimize nonspecific binding of test samples to the app.  The device is reusable, easily assembled, and can be shaken in controlled temp. environments to decrease the time required to reach equil. as well as facilitate dissoln. of test compds.  Plasma protein binding values obtained for 10 diverse compds. using std. dialysis equipment and the 96-well dialysis block validates this method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp9qyX_9tHHrVg90H21EOLACvtfcHk0lh-bP4Vd5gLpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1ehsrs%253D&md5=0948f0a11373c57be06be9e0d604ad40</span></div><a href="/servlet/linkout?suffix=ref30_1&amp;dbid=16384&amp;doi=10.1002%2Fjps.10332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10332%26sid%3Dliteratum%253Aachs%26aulast%3DBanker%26aufirst%3DM.%2BJ.%26aulast%3DClark%26aufirst%3DT.%2BH.%26aulast%3DWilliams%26aufirst%3DJ.%2BA.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%252096-well%2520equilibrium%2520dialysis%2520apparatus%2520for%2520measuring%2520plasma%2520protein%2520binding%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D967%26epage%3D974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KBC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KBC','PDB','4KBC'); return false;">PDB: 4KBC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KB8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KB8','PDB','4KB8'); return false;">PDB: 4KB8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KBA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KBA','PDB','4KBA'); return false;">PDB: 4KBA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KBK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KBK','PDB','4KBK'); return false;">PDB: 4KBK</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm4006324&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-17%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm4006324%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm4006324" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677aecea6c0623e0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
